WataruYasui

Last Updated :2019/10/06

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medicine), ., Professor
Web Site
E-mail
wyasuihiroshima-u.ac.jp
Self-introduction
Pathology is an integrated medical science that studies the causes and mechanisms of disease, and is the foundation of medical science and practice. There are two main pillars in pathology; pathological diagnosis and experimental pathology. We place equal emphasis on both fields at our laboratory, and widely contribute to clinical practice and development of advanced medicine.

Basic Information

Major Professional Backgrounds

  • 1986/04/01, 1987/06/30, Hiroshima University, First Department of Pathology, Research Assistant
  • 1987/07/01, 1989/04/30, Research Institute of Scripps Clinic, Dept. of Molecular and Experimental Medicine, Research Fellow
  • 1989/08/01, 1992/09/30, Hiroshima University, First Department of Pathology, Assistant Professor
  • 1992/10/01, 2000/05/31, Hiroshima University, First Department of Pathology, Associate Professor
  • 2000/06/01, 2002/03/31, Hiroshima University, First Department of Pathology, Professor
  • 2002/04/01, 2019/03/31, Hiroshima University, Department of Molecular Pathology, Professor
  • 2012/04/01, 2013/03/31, Hiroshima University, Vice Executive
  • 2013/03/15, Hiroshima University, Distinguished Professor
  • 2014/04/01, 2017/03/31, Hiroshima University, Institute of Biomedical & Health Sciences, Director
  • 2014/04/01, 2018/03/31, Hiroshima University, Graduate School of Biomedical & Health Sciences, Dean
  • 2018/04/01, Hiroshima University, Office of Academic Research, Vice Executive

Educational Backgrounds

  • Hiroshima University, Graduate School of Medical Sciences, Japan, 1982/04, 1986/03
  • Hiroshima University, Faculty of Medicine, Japan, 1976/04, 1982/03

Academic Degrees

  • Doctor of Medical Science, Hiroshima University
  • Doctor of Medicine, Hiroshima University

Educational Activity

  • 【Bachelor Degree Program】School of Medicine : Program of Medicine
  • 【Master's Program】Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • 【Doctoral Program】Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Basic medicine;Human pathology

Research Keywords

  • Tumor Molecular Moprhology
  • Molecular Pathological Diagnosis
  • Transcriptome Dissection
  • Identification of Novel Diagnostic and Therapeutic Targets
  • Cancer Stem Cell
  • Organoid biology
  • Molecular Basis of Gastrointestinal Cancer
  • Molecular Basis of Urological Cancer
  • non-coding RNAs
  • Gene Regulation and Epigenetics

Affiliated Academic Societies

  • Japanese Society of Pathology, 1982
  • Japanese Cancer Association, 1998
  • Japanese Gastric Cancer Association, 1998
  • American Association for Cancer Research, 1992
  • The International Gastric Cancer Association, 1995
  • International Academy of Pathology, 1989
  • International Society of Gastroenterological Carcinogenesis (ISGC), 1996
  • Japanese Society for Gastroenterological Carcinogenesis, 1995
  • Japanese Society of Clinical Cytology, 1990
  • Japanese Association for Metastasis Research, 1998
  • Japanese Society of Gastroenterology, 1994
  • Japanese Society of Molecular Pathology, 1989
  • Japanese Society for Molecular Tumor Marker Research, 1989
  • The Japanese Biochemical Society, 1982

Educational Activity

Course in Charge

  1. 2019, Undergraduate Education, 2Term, Introduction for medical research
  2. 2019, Undergraduate Education, Intensive, Practice for medical research
  3. 2019, Undergraduate Education, First Semester, General Pathology
  4. 2019, Undergraduate Education, First Semester, Pathology
  5. 2019, Undergraduate Education, First Semester, Pathology
  6. 2019, Undergraduate Education, First Semester, Outline of Pathology
  7. 2019, Graduate Education (Doctoral Program) , First Semester,
  8. 2019, Graduate Education (Master's Program) , Second Semester, Pathologic basis of diseases
  9. 2019, Graduate Education (Master's Program) , First Semester, Seminar on Molecular Pathology
  10. 2019, Graduate Education (Master's Program) , Second Semester, Seminar on Molecular Pathology
  11. 2019, Graduate Education (Master's Program) , First Semester, Research on Molecular Pathology
  12. 2019, Graduate Education (Master's Program) , Second Semester, Research on Molecular Pathology
  13. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Molecular Pathology
  14. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Molecular Pathology
  15. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced research on Molecular Pathology
  16. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Molecular Pathology
  17. 2019, Graduate Education (Doctoral Program) , First Semester,
  18. 2019, Graduate Education (Doctoral Program) , Second Semester,
  19. 2019, Graduate Education (Master's Program) , First Semester, Seminar
  20. 2019, Graduate Education (Master's Program) , Second Semester, Seminar
  21. 2019, Graduate Education (Master's Program) , First Semester, Research
  22. 2019, Graduate Education (Master's Program) , Second Semester, Research
  23. 2019, Graduate Education (Master's Program) , Second Semester, Pathologic Basis of Diseases
  24. 2019, Graduate Education (Doctoral Program) , 1Term, Cause of Death Investigation

Research Activities

Academic Papers

  1. IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma, NATURE CELL BIOLOGY, 21(8), 1003-+, 201908
  2. Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts, ONCOGENE, 38(28), 5566-5579, 20190711
  3. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 24(7), 771-778, 201907
  4. Transcribed ultraconserved region Uc.63+promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer, ONCOLOGY REPORTS, 41(5), 3111-3118, 201905
  5. Characteristics of 5015 Salivary Gland Neoplasms Registered in the Hiroshima Tumor Tissue Registry over a Period of 39 Years, JOURNAL OF CLINICAL MEDICINE, 8(5), 201905
  6. Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients, PROSTATE, 79(2), 234-242, 20190201
  7. Clinicopathological significance of RCAN2 production in gastric carcinoma, HISTOPATHOLOGY, 74(3), 430-442, 201902
  8. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer, JOURNAL OF CLINICAL MEDICINE, 8(2), 201902
  9. Clinicopathological significance of claspin overexpression and its association with spheroid formation in gastric cancer, HUMAN PATHOLOGY, 84, 8-17, 201902
  10. Deficiency of Stomach-Type Claudin-18 in Mice Induces Gastric Tumor Formation Independent of H pylori Infection, CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 8(1), 119-142, 2019
  11. SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival, PATHOBIOLOGY, 86(4), 208-216, 2019
  12. Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model, PLOS ONE, 14(6), 20190626
  13. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma, ONCOLOGY, 97(3), 164-172, 2019
  14. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(16), 20190802
  15. Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48(9), 841-849, SEP 2018
  16. Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0), CANCER SCIENCE, 109(9), 2980-2985, SEP 2018
  17. Uc.416+A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma, BMC CANCER, 18, OCT 4 2018
  18. Signal regulatory protein alpha blockade potentiates tumoricidal effects of macrophages on gastroenterological neoplastic cells in syngeneic immunocompetent mice, ANNALS OF GASTROENTEROLOGICAL SURGERY, 2(6), 451-462, 201811
  19. Association between histological features of epicardial adipose tissue and coronary plaque characteristics on computed tomography angiography, HEART AND VESSELS, 33(8), 827-836, 201808
  20. Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis, ABDOMINAL RADIOLOGY, 43(7), 1540-1545, 201807
  21. Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer, TRANSLATIONAL ONCOLOGY, 11(3), 575-584, 201806
  22. Clinicopathological and Prognostic Significance of Epithelial Gremlin1 Expression in Gastric Cancer, ANTICANCER RESEARCH, 38(3), 1419-1425, 201803
  23. Pseudomesotheliomatous carcinoma of the pleura: an autopsy case of metastasis from a G-CSF-producing anaplastic carcinoma of the pancreas, APMIS, 126(2), 166-170, 201802
  24. An extremely rare case of Epstein-Barr virus-associated gastric carcinoma with differentiation to neuroendocrine carcinoma, PATHOLOGY INTERNATIONAL, 68(1), 41-46, 201801
  25. Tumor Necrosis Factor-alpha Gene Expression in Epicardial Adipose Tissue is Related to Coronary Atherosclerosis Assessed by Computed Tomography, JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 25(3), 269-280, 2018
  26. Overexpression of the Transmembrane Protein IQGAP3 Is Associated with Poor Survival of Patients with Gastric Cancer, PATHOBIOLOGY, 85(3), 192-200, 2018
  27. Anastomosing haemangioma with fatty changes in the perirenal space: a lesion mimicking liposarcoma, BJR CASE REPORTS, 4(2), 2018
  28. A case of ascending colon cancer accompanied with tumor thrombosis in the superior mesenteric vein treated with right hemicolectomy and greater saphenous vein grafting, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 51, 358-363, 2018
  29. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma, ONCOLOGY, 95(5), 297-308, 2018
  30. INTRAMURAL FLORID CYSTIC ENDOSALPINGIOSIS OF THE UTERUS AFTER MENOPAUSE, POLISH JOURNAL OF PATHOLOGY, 69(3), 321-324, 2018
  31. Transcribed ultraconserved region Uc.63+promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer, ONCOTARGET, 8(55), 94259-94270, 20171107
  32. Long-term follow-up study of gastric adenoma; tumor-associated macrophages are associated to carcinoma development in gastric adenoma, GASTRIC CANCER, 20(6), 929-939, 201711
  33. Expression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer, GASTRIC CANCER, 20(6), 960-969, 201711
  34. Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma, CANCER MEDICINE, 6(10), 2308-2320, 201710
  35. Serous adenocarcinoma of retroperitoneum: a case report, INTERNATIONAL CANCER CONFERENCE JOURNAL, 6(4), 154-157, 201710
  36. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer, JOURNAL OF PATHOLOGY, 243(1), 100-110, 201709
  37. Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer, INTERNATIONAL JOURNAL OF UROLOGY, 24(8), 594-600, 201708
  38. A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients, ONCOLOGY LETTERS, 14(1), 299-305, 201707
  39. Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer, ONCOLOGY LETTERS, 14(1), 999-1004, 201707
  40. Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification, ABDOMINAL RADIOLOGY, 42(7), 1850-1856, 201707
  41. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma, ANTICANCER RESEARCH, 37(6), 2853-2860, 201706
  42. Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact, NEOPLASIA, 19(5), 429-438, 201705
  43. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer, ANNALS OF SURGICAL ONCOLOGY, 24(2), 594-602, 201702
  44. Characteristic expression of fukutin in gastric cancer among atomic bomb survivors, ONCOLOGY LETTERS, 13(2), 937-941, 201702
  45. SIX1 maintains tumor basal cells via transforming growth factor- pathway and associates with poor prognosis in esophageal cancer, CANCER SCIENCE, 108(2), 216-225, 201702
  46. BRAF(V600E) cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis, ELIFE, 6, 20170110
  47. KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells, ANTICANCER RESEARCH, 37(1), 47-55, 201701
  48. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 35(1), 201701
  49. Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression, CANCER SCIENCE, 108(1), 143-150, 201701
  50. Regeneration of rat corpora cavernosa tissue by transplantation of CD133(+) cells derived from human bone marrow and placement of biodegradable gel sponge sheet, ASIAN JOURNAL OF ANDROLOGY, 19(2), 203-207, 2017
  51. Overexpression of KIFC1 and its association with spheroid formation in esophageal squamous cell carcinoma, PATHOLOGY RESEARCH AND PRACTICE, 213(11), 1388-1393, 2017
  52. Non-coding RNAs are promising targets for stem cell-based cancer therapy, Non-coding RNA Research, 2(2), 83-87, 2017
  53. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation, PLOS ONE, 11(11), 20161111
  54. Pure invasive micropapillary carcinoma of the esophagogastric junction with lymph nodes and liver metastasis, PATHOLOGY INTERNATIONAL, 66(10), 583-586, 201610
  55. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, 20160909
  56. Overexpression of KIF11 in Gastric Cancer with Intestinal Mucin Phenotype, PATHOBIOLOGY, 84(1), 16-24, 201609
  57. Clinicopathologic characteristics and management of minute esophageal lesions diagnosed by narrow-band imaging endoscopy, ENDOSCOPY INTERNATIONAL OPEN, 4(9), E927-E932, 201609
  58. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer, ONCOGENESIS, 5, 201608
  59. ALK(R1275Q) perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN, ONCOGENE, 35(34), 4447-4458, 201608
  60. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation, ONCOGENE, 35(27), 3598-3606, 20160707
  61. Induction of KIFC1 expression in gastric cancer spheroids, ONCOLOGY REPORTS, 36(1), 349-355, 201607
  62. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma, CANCER MEDICINE, 5(7), 1546-1555, 201607
  63. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras, JOURNAL OF GASTROENTEROLOGY, 51(5), 447-457, 201605
  64. Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma, CANCER SCIENCE, 107(5), 601-608, 201605
  65. Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer, GASTRIC CANCER, 19(2), 443-452, 201604
  66. A case of tubulocystic carcinoma of the kidney with aggressive features, JAPANESE JOURNAL OF RADIOLOGY, 34(4), 307-311, 201604
  67. TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer, GASTRIC CANCER, 19(2), 370-380, 2016
  68. Regression of Cecal MALT Lymphoma after Antibiotic Treatment in a Patient with Helicobacter pylori Infection, INTERNAL MEDICINE, 55(2), 135-139, 2016
  69. Increased Calcineurin A Expression Is Associated with a Lower Relapse-Free Survival Rate after Colorectal Cancer Surgery, PATHOBIOLOGY, 83(6), 308-315, 2016
  70. Balloon Cell Malignant Melanoma in a Young Female: A Case Report and Review of the Literature, CASE REPORTS IN ONCOLOGY, 9(1), 262-266, 2016
  71. Russell body gastritis concurrent with eosinophilia: a case report, Hiroshima J Med Sci, 65(3-4), 69-72, 2016
  72. Stochastic resonance enhanced tactile feedback in laparoscopic surgery, SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(12), 3811-3818, 201512
  73. The relationship between inflammation and neoangiogenesis of epicardial adipose tissue and coronary atherosclerosis based on computed tomography analysis, ATHEROSCLEROSIS, 243(1), 293-299, 201511
  74. TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer, CANCER MEDICINE, 4(11), 1667-1678, 201511
  75. High-grade epithelial-myoepithelial carcinoma of the parotid gland with mucous cell differentiation, PATHOLOGY INTERNATIONAL, 65(9), 490-494, 201509
  76. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype, CANCER SCIENCE, 106(8), 951-958, 201508
  77. Chlorinated Water Modulates the Development of Colorectal Tumors with Chromosomal Instability and Gut Microbiota in Apc-Deficient Mice, PLOS ONE, 10(7), 20150717
  78. Vasculo-smooth muscle hamartomatous structure is linked to morphogenesis of colorectal polypoid adenoma, MEDICAL MOLECULAR MORPHOLOGY, 48(2), 112-115, 201506
  79. Aberrant DNA Methylation of DLX4 and SIM1 is a Predictive Marker for Disease Progression of Uterine Cervical Low-Grade Squamous Intraepithelial Lesion, DIAGNOSTIC CYTOPATHOLOGY, 43(6), 462-470, 201506
  80. Characteristic miR-24 Expression in Gastric Cancers among Atomic Bomb Survivors, PATHOBIOLOGY, 82(2), 68-75, 2015
  81. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer, PATHOBIOLOGY, 82(5), 233-241, 2015
  82. The Potential Role of Inflammation Associated with Interaction between Osteopontin and CD44 in a Case of Pulmonary Tumor Thrombotic Microangiopathy Caused by Breast Cancer, INTERNAL MEDICINE, 54(22), 2877-2880, 2015
  83. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer, ONCOLOGY REPORTS, 32(4), 1720-1726, 201410
  84. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 32(6), 769-778, 201408
  85. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-alpha secretion in gastric cancer, ONCOGENE, 33(30), 3918-3926, 20140724
  86. Clinicopathological significance of MMP-7, laminin gamma 2 and EGFR expression at the invasive front of gastric carcinoma, GASTRIC CANCER, 17(3), 412-422, 201407
  87. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer, ONCOLOGY REPORTS, 32(1), 403-410, 201407
  88. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer, INTERNATIONAL JOURNAL OF CANCER, 134(8), 1926-1934, 20140415
  89. Canonical Wnt signals combined with suppressed TGF beta/BMP pathways promote renewal of the native human colonic epithelium, GUT, 63(4), 610-621, 201404
  90. Alpha-fetoprotein-producing clear cell carcinoma of the gallbladder with neuroendocrine differentiation, MEDICAL MOLECULAR MORPHOLOGY, 47(1), 54-56, 201403
  91. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer, CANCER SCIENCE, 105(2), 228-235, 201402
  92. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis, CANCER SCIENCE, 105(2), 236-243, 201402
  93. NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression, CANCER SCIENCE, 105(1), 134-140, 201401
  94. Identification of Novel Transmembrane Proteins in Scirrhous-Type Gastric cancer by the Escherichia coli Ampicillin Secretion Trap (CAST) Method: TM9SF3 Participates in Tumor Invasion and Serves as a Prognostic Factor, PATHOBIOLOGY, 81(3), 138-148, 2014
  95. Oligophrenin-1 Is Associated with Cell Adhesion and Migration in Prostate Cancer, PATHOBIOLOGY, 81(4), 190-198, 2014
  96. Canonical Wnt signals combined with suppressed TGF beta/BMP pathways promote renewal of the native human colonic epithelium, GUT, 63(4), 610-621, 2014
  97. Interaction between bone marrow-derived mesenchymal stem cells and tumor cells induces expression of fibronectin in human colon cancer cells, CANCER RESEARCH, 74(19), 2014
  98. Combining Molecular Targeted Drugs to Inhibit Both Cancer Cells and Activated Stromal Cells in Gastric Cancer, NEOPLASIA, 15(12), 1391-1399, 201312
  99. New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers, ONCOLOGY REPORTS, 30(6), 2609-2616, 201312
  100. Resistin-Like Molecule Is Abundantly Expressed in Foam Cells and Is Involved in Atherosclerosis Development, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 33(8), 1986-1993, 201308
  101. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells, GASTRIC CANCER, 16(3), 345-354, 201307
  102. Expression of olfactomedin 4 and claudin-18 in serrated neoplasia of the colorectum: a characteristic pattern is associated with sessile serrated lesion, HISTOPATHOLOGY, 62(7), 1018-1027, 201306
  103. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma, INTERNATIONAL JOURNAL OF UROLOGY, 20(5), 468-477, 201305
  104. MicroRNAs in Cancer: The 22nd Hiroshima Cancer Seminar/The 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43(5), 579-582, 201305
  105. Expression of podoplanin/D2-40 in pericryptal stromal cells in superficial colorectal epithelial neoplasia, MEDICAL MOLECULAR MORPHOLOGY, 46(1), 20-23, 201303
  106. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer, INTERNATIONAL JOURNAL OF CANCER, 132(4), 813-823, 20130215
  107. Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature, VIRCHOWS ARCHIV, 462(2), 239-248, 201302
  108. Improved PCR amplification for molecular analysis using DNA from long-term preserved formalin-fixed, paraffin-embedded lung cancer tissue specimens, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 6(1), 76-79, 2013
  109. Meeting Report "MicroRNAs in Cancer: The 22nd Hiroshima Cancer Seminar/the 4th Japanese Association for RNA interference Joint International Symposium, 30 August 2012, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43, 579-582, 2013
  110. The Search for Secreted Proteins in Prostate Cancer by the Escherichia coli Ampicillin Secretion Trap: Expression of NBL1 Is Highly Restricted to the Prostate and Is Related to Cancer Progression, PATHOBIOLOGY, 80(2), 60-69, 2013
  111. A possible therapeutic agent for pulmonary fibrosis: Antibody against integrin alpha 8 beta 1, EUROPEAN RESPIRATORY JOURNAL, 42, 2013
  112. Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature (vol 462, pg 239, 2013), VIRCHOWS ARCHIV, 462(3), 369-369, 2013
  113. Interaction between bone marrow-derived mesenchymal stem cells and tumor cells induces metallothionein gene expression in human colon cancer, CANCER RESEARCH, 73(8), 2013
  114. Search for biomarkers of stage II/III gastric cancer and development of individualized therapy., JOURNAL OF CLINICAL ONCOLOGY, 31(15), 2013
  115. Clinicopathological features of minute pharyngeal lesions diagnosed by narrow-band imaging endoscopy and biopsy, WORLD JOURNAL OF GASTROENTEROLOGY, 18(44), 6468-6474, 20121128
  116. Reg IV Is a Direct Target of Intestinal Transcriptional Factor CDX2 in Gastric Cancer, PLOS ONE, 7(11), 20121102
  117. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer, CANCER SCIENCE, 103(9), 1744-1750, 201209
  118. Infantile adenomyoma subclinically excreted into the patient's diaper, PATHOLOGY INTERNATIONAL, 62(8), 532-537, 201208
  119. Primary mammary mucinous cystadenocarcinoma: Cytological and histological findings, DIAGNOSTIC CYTOPATHOLOGY, 40(7), 624-628, 201207
  120. Cytokeratin 7 is a Predictive Marker for Survival in Patients with Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 19(6), 1902-1910, 201206
  121. Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD, JOURNAL OF CROHNS & COLITIS, 6(4), 425-434, 201205
  122. Deficiency of Claudin-18 Causes Paracellular H+ Leakage, Up-regulation of Interleukin-1 beta, and Atrophic Gastritis in Mice, GASTROENTEROLOGY, 142(2), 292-304, 201202
  123. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer, PATHOLOGY INTERNATIONAL, 62(2), 112-119, 201202
  124. Claudin-based paracellular proton barrier in the stomach, ANN NY ACADEMY OF SCIENCE, 1258, 108-114, 2012
  125. Cytokeratin Expression Profiling in Gastric Carcinoma: Clinicopathologic Significance and Comparison with Tumor-Associated Molecules, PATHOBIOLOGY, 79(3), 154-161, 2012
  126. Meeting Report “Recent Progress in Carcinogenesis, Progression and Management of Upper GI Cancer: The 21st Hiroshima Cancer Seminar-the 5th Three Universities’ Consortium International Symposium, November 2011, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 42, 351-356, 2012
  127. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis, CARCINOGENESIS, 33(5), 1081-1088, 2012
  128. SAGE of esophageal squamous cell carcinoma: identification of a new chemical biomarker in esophageal squamous cell carcinoma, NRD1, Japan Journal of Molecular Tumor Marker Research, 27, 71-72, 2012
  129. Presence of vascular adventitial fibroblastic cells in diffuse-type gastric carcinomas, JOURNAL OF CLINICAL PATHOLOGY, 57(9), 970-972, 200409
  130. Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma, HISTOPATHOLOGY, 59(4), 710-721, 201110
  131. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model, INTERNATIONAL JOURNAL OF CANCER, 128(9), 2050-2062, 20110501
  132. A Functional Single Nucleotide Polymorphism in Mucin 1, at Chromosome 1q22, Determines Susceptibility to Diffuse-Type Gastric Cancer, GASTROENTEROLOGY, 140(3), 892-902, 201103
  133. Serum concentration and expression of Reg IV in patients with esophageal cancer: Age-related elevation of serum Reg IV concentration, ONCOLOGY LETTERS, 2(2), 235-239, 2011
  134. Future Perspective of Gastric Cancer Treatment - From Bench to Bedside - , PATHOBIOLOGY, 78, 293-294, 2011
  135. Identification of Transmembrane Protein in Prostate Cancer by the Escherichia coli Ampicillin Secretion Trap: Expression of CDON Is Involved in Tumor Cell Growth and Invasion, PATHOBIOLOGY, 78(5), 277-284, 2011
  136. Meeting Report "Recent progress in carcinogenesis, progression and therapy of breast cancer. The 20th Hiroshima Cancer Seminar-the 4th Three Universities' Consortium International Symposium, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 924-930, 2011
  137. Molecular pathology of gastric cancer: Research and practice, PATHOLOGY RESEARCH AND PRACTICE, 207(10), 608-612, 2011
  138. Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(46), 20027-20032, 20101116
  139. Mesenchymal stem cells enhance growth and metastasis of colon cancer, INTERNATIONAL JOURNAL OF CANCER, 127(10), 2323-2333, 20101115
  140. Immunohistochemical analysis of colorectal cancer with gastric phenotype: Claudin-18 is associated with poor prognosis, PATHOLOGY INTERNATIONAL, 60(10), 673-680, 201010
  141. Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor beta is associated with lymphatic metastasis in human gastric carcinoma, CANCER SCIENCE, 101(9), 1984-1989, 201009
  142. Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype, JOURNAL OF PATHOLOGY, 221(3), 275-284, 201007
  143. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase, ONCOGENE, 29(14), 2036-2046, 20100408
  144. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin, PATHOLOGY INTERNATIONAL, 60(4), 291-297, 201004
  145. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma, CANCER SCIENCE, 101(4), 1038-1044, 201004
  146. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis, LANCET ONCOLOGY, 11(2), 136-146, 201002
  147. Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancer, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 1(1), 73-78, 2010
  148. Upregulation of Connexin 30 in Intestinal Phenotype Gastric Cancer and Its Reduction during Tumor Progression, PATHOBIOLOGY, 77(5), 241-248, 2010
  149. CDX2 Regulates Multidrug Resistance 1 Gene Expression in Malignant Intestinal Epithelium, CANCER RESEARCH, 70(17), 6767-6778, 2010
  150. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma, CANCER SCIENCE, 101(4), 1038-1044, 2010
  151. Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells, CANCER SCIENCE, 101(10), 2121-2127, 2010
  152. Serum olfactomedin 4 (GWI 12, hGC4) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients, INTERNATIONAL JOURNAL OF CANCER, 125(10), 2383-2392, 20091115
  153. Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer, CANCER RESEARCH, 69(16), 6694-6703, 20090815
  154. Laminin gamma 2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells, GASTROENTEROLOGY, 137(1), 242-252, 200907
  155. h-prune Is an Independent Prognostic Marker for Survival in Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 16(5), 1390-1396, 200905
  156. Characteristic gene expression in stromal cells of gastric cancers among atomic-bomb survivors, INTERNATIONAL JOURNAL OF CANCER, 124(5), 1112-1121, 20090301
  157. Transcriptome dissection of gastric cancer: Identification of novel diagnostic and therapeutic targets from pathology specimens, PATHOLOGY INTERNATIONAL, 59(3), 121-136, 200903
  158. Reg IV enhances peritoneal metastasis in gastric carcinomas, CELL PROLIFERATION, 42(1), 110-121, 200902
  159. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker, ONCOLOGY REPORTS, 21(1), 95-100, 200901
  160. Meeting Report "Recent Progress in Pathogenesis and Management of Colorectal Cancer: The Eighteenth International Symposium of Hiroshima Cancer Seminar, November 2008, CANCER SCIENCE, 100, 978-981, 2009
  161. Recent progress in pathogenesis and management of colorectal cancer. Eighteenth International Symposium of the Hiroshima Cancer Seminar, November 2008, CANCER SCIENCE, 100(5), 978-981, 2009
  162. Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland, HISTOPATHOLOGY, 53(6), 667-675, 200812
  163. Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms, CLINICAL CANCER RESEARCH, 14(22), 7205-7214, 20081115
  164. Positive immunohistochemical staining of gamma H2AX is associated with tumor progression in gastric cancers from radiation-exposed patients, ONCOLOGY REPORTS, 20(5), 1131-1136, 200811
  165. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose, CANCER RESEARCH, 68(17), 7176-7182, 20080901
  166. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma, CANCER SCIENCE, 99(9), 1806-1812, 200809
  167. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 32(8), 1182-1189, 200808
  168. Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer, CANCER SCIENCE, 99(8), 1570-1577, 200808
  169. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer, NATURE GENETICS, 40(6), 730-740, 200806
  170. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 21(5), 599-604, 200805
  171. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach, MODERN PATHOLOGY, 21(4), 464-475, 200804
  172. Presence of perivenular elastic fibers in nonalcoholic steatohepatitis Fibrosis Stage III, HISTOLOGY AND HISTOPATHOLOGY, 23(4), 407-409, 200804
  173. In Silico analysis of Gastric carcinoma Serial Analysis of Gene Expression libraries reveals different profiles associated with ethnicity, MOLECULAR CANCER, 7, 20080227
  174. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastasis, ANTICANCER RESEARCH, 28(2B), 1169-1179, 2008
  175. Presence of perivenular elastic fibers in nonalcoholic steatohepatitis Fibrosis Stage III, HISTOLOGY AND HISTOPATHOLOGY, 23(4), 407-409, 2008
  176. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 21(5), 599-604, 2008
  177. Radiation therapy for Cancer - The Fifteenth Anniversary of Hiroshima Cancer Seminar Foundation, the Seventeenth International Symposium of Hiroshima Cancer Seminar, November 2007, CANCER SCIENCE, 99(6), 1287-1291, 2008
  178. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 32(8), 1182-1189, 2008
  179. Olfactomedin 4 and Reg IV: Novel Serum Biomarkers for Gastric Cancer Patients, TUMOR BIOLOGY, 29, 67-67, 2008
  180. Immunohistochemical Analysis and Serum Concentration of Reg IV in Patients with Esophageal Cancer, TUMOR BIOLOGY, 29, 79-79, 2008
  181. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high Reg IV serum level is associated with liver metastasis, Japan Journal of Molecular Tumor Marker Research, 23, 21-22, 2008
  182. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas, CANCER RESEARCH, 67(24), 11601-11611, 20071215
  183. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer, CANCER SCIENCE, 98(12), 1902-1913, 200712
  184. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer, CLINICAL CANCER RESEARCH, 13(22), 6624-6631, 20071115
  185. Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer., CLINICAL CANCER RESEARCH, 13(22), 6624-6631, 20071115
  186. Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer, CANCER SCIENCE, 98(8), 1198-1205, 200708
  187. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer, ONCOLOGY REPORTS, 18(2), 329-336, 200708
  188. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy, ONCOGENE, 26(30), 4383-4393, 200706
  189. DNA demethylation of Vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer, INTERNATIONAL JOURNAL OF CANCER, 120(8), 1689-1695, 20070415
  190. Meeting Report "Cancer Stem Cell: The Sixteenth International Symposium of the Hiroshima Cancer Seminar, October 2006”, CANCER SCIENCE, 98, 753-756, 20070101
  191. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma, APMIS, 115, 1422-1425, 20070101
  192. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer, CANCER SCIENCE, 98(1), 32-36, 200701
  193. Serum concentration of Reg IV in patients with colorectal cancer: Overexpression and high serum levels of Reg IV are associated with liver metastasis, ONCOLOGY, 72(5-6), 371-380, 2007
  194. Cancer stem cells - The Sixteenth International Symposium of the Hiroshima Cancer Seminar, October 2006, CANCER SCIENCE, 98(5), 753-756, 2007
  195. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer, ONCOLOGY REPORTS, 18(2), 329-336, 2007
  196. HMGB1-inducible MIA is associated with nodal metastasis in oral squamous cell carcinoma, CLINICAL & EXPERIMENTAL METASTASIS, 24(4), 288-289, 2007
  197. High expression of h-prune in gastric cancer with gastric phenotype : expression of h-prune is associated with poor survival in gastric cancer, CLINICAL & EXPERIMENTAL METASTASIS, 24(4), 291-291, 2007
  198. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma, APMIS, 115(12), 1422-1425, 2007
  199. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion, CANCER RESEARCH, 66(21), 10439-10448, 20061101
  200. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer, CANCER RESEARCH, 66(19), 9408-9419, 20061001
  201. Gene expression profiles of small-cell lung cancers: Molecular signatures of lung cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 29(3), 567-575, 200609
  202. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer, CANCER SCIENCE, 97(8), 737-745, 200608
  203. Clinicopathologic and genetic characteristics of gastric cancer in young male and female patients, ONCOLOGY REPORTS, 16(1), 11-15, 200607
  204. Improved RT-PCR amplification for molecular analyses with long-term preserved formalin-fixed, paraffin-embedded tissue specimens, JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 54(7), 773-780, 200607
  205. Lack of pericryptal fibroblastic cells adjacent to intestinal epithelial metaplastic glands, HISTOPATHOLOGY, 48, 610-612, 20060401
  206. Meeting Report "Current progress of cancer chemotherapy": The Fifteenth International Symposium of the Hiroshima Cancer Seminar, October 2005”, CANCER SCIENCE, 97, 328-331, 20060401
  207. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors, ONCOLOGY REPORTS, 15(4), 933-938, 200604
  208. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas, VIRCHOWS ARCHIV, 448(4), 428-434, 200604
  209. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype, JOURNAL OF PATHOLOGY, 208(5), 633-642, 200604
  210. Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype, PATHOLOGY INTERNATIONAL, 56(4), 200-205, 200604
  211. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer, ONCOGENE, 25(17), 2546-2557, 200604
  212. Accumulation of DNA methylation is associated with tumor stage in gastric cancer, CANCER, 106(6), 1250-1259, 20060315
  213. Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions, MOLECULAR AND CELLULAR BIOLOGY, 26(3), 898-911, 200602
  214. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer, ANTICANCER RESEARCH, 26(1A), 49-54, 2006
  215. Molecular pathobiology of gastric cancer, SCANDINAVIAN JOURNAL OF SURGERY, 95(4), 225-231, 2006
  216. Nuclear and mitochondrial DNA microsatellite instability in gastrointestinal stromal tumors, PATHOBIOLOGY, 73(2), 93-97, 2006
  217. Gene expression profiles of small-cell lung cancers: Molecular signatures of lung cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 29(3), 567-575, 2006
  218. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population, ONCOLOGY REPORTS, 14(5), 1151-1154, 200511
  219. Somatic mutations of mitochondrial DNA in digestive tract cancers, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 20(11), 1679-1684, 200511
  220. DNA methylation of genes linked with retinoid signaling in gastric carcinoma - Expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation, CANCER, 104(8), 1609-1619, 20051015
  221. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer, VIRCHOWS ARCHIV, 447(4), 717-722, 200510
  222. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma, JOURNAL OF PATHOLOGY, 207(2), 185-198, 200510
  223. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage, CANCER SCIENCE, 96(9), 571-577, 200509
  224. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan, ONCOLOGY REPORTS, 14(2), 465-470, 200508
  225. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes, CANCER SCIENCE, 96(8), 474-479, 200508
  226. G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell, CANCER IMMUNOLOGY IMMUNOTHERAPY, 54(8), 729-740, 200508
  227. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes, INTERNATIONAL JOURNAL OF CANCER, 115(3), 388-392, 20050620
  228. Meeting Report "Cancer and epigenetics - basic research and clinical implication - Joint Meeting of the Fourteenth International Symposium of the Hiroshima Cancer Seminar and the Eighth Meeting of the Tottori Bioscience Promotion Foundation, October 2004”, CANCER SCIENCE, 96, 245-248, 20050401
  229. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes., INTERNATIONAL JOURNAL OF CANCER, 115, 388-392, 20050401
  230. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 21(5), 559-566, 20050301
  231. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma, ONCOGENE, 24(1), 157-164, 20050106
  232. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 131(1), 19-25, 200501
  233. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma, JOURNAL OF PATHOLOGY, 205(1), 65-73, 200501
  234. A single nucleotide polymorphism in the 5 ' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer, PATHOBIOLOGY, 72(3), 133-138, 2005
  235. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression, ONCOLOGY, 69, 17-22, 2005
  236. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 112(6), 1003-1009, 20041220
  237. ADAM8 as a novel serological and histochemical marker for lung cancer, CLINICAL CANCER RESEARCH, 10(24), 8363-8370, 20041215
  238. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality, ONCOLOGY REPORTS, 12(5), 985-990, 200411
  239. Single nucleotide polymorphism in the hypoxia-inducible factor-1 alpha gene in colorectal carcinoma, ONCOLOGY REPORTS, 12(5), 1033-1037, 200411
  240. Characterization of vitamin D-mediated induction of the CYP 24 transcription, MOLECULAR AND CELLULAR ENDOCRINOLOGY, 226(1-2), 27-32, 20041029
  241. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells, INTERNATIONAL JOURNAL OF ONCOLOGY, 25(3), 579-595, 200409
  242. Chromosomal and microsatellite instability in sporadic gastric cancer, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 19(7), 756-760, 200407
  243. High molecular weight caldesmon positive stromal cells in the capsule of hepatocellular carcinomas, JOURNAL OF CLINICAL PATHOLOGY, 57(7), 776-777, 200407
  244. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 110(2), 212-218, 20040610
  245. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 130(5), 259-265, 200405
  246. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications, CANCER SCIENCE, 95(5), 385-392, 200405
  247. Adenocarcinoma arising from a gastric duplication cyst with invasion to the stomach: a case report with literature review, JOURNAL OF CLINICAL PATHOLOGY, 57(4), 428-431, 20040401
  248. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression, CANCER RESEARCH, 64(7), 2397-2405, 20040401
  249. Meeting Report "New approaches to identification of biomarkers for early cancer detection": The Thirteenth International Symposium of the Hiroshima Cancer Seminar, October 2003, CANCER SCIENCE, 95, 193-195, 20040401
  250. Molecular-pathological prognostic factor of gastric cancer: a review, GASTRIC CANCER, 8, 86-94, 20040401
  251. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implication, CANCER SCIENCE, 95, 385-392, 20040401
  252. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma, VIRCHOWS ARCHIV, 444(4), 324-331, 200404
  253. Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas, JOURNAL OF CLINICAL PATHOLOGY, 57(2), 183-185, 20040201
  254. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma, CANCER RESEARCH, 64(2), 523-529, 20040115
  255. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2N-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil, ONCOLOGY REPORTS, 11(1), 9-15, 200401
  256. Expression of RhoC is associated with metastasis of gastric carcinomas, PATHOBIOLOGY, 71(1), 19-25, 2004
  257. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma, PATHOBIOLOGY, 71(3), 137-143, 2004
  258. Promoter methylation of cyclin D2 gene in gastric carcinoma, INTERNATIONAL JOURNAL OF ONCOLOGY, 23(6), 1663-1670, 200312
  259. Small cell carcinoma of the extrahepatic bile duct: Case report and immunohistochemical analysis, PATHOLOGY INTERNATIONAL, 53(12), 887-891, 200312
  260. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 311(4), 809-814, 20031128
  261. A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer, INTERNATIONAL JOURNAL OF CANCER, 107(4), 593-596, 20031120
  262. Hypoxia-inducible factor-1 alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance, CARCINOGENESIS, 24(11), 1779-1783, 200311
  263. Rapid and preferential induction of ATF3 transcription in response to low doses of UVA light, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 310(4), 1168-1174, 20031031
  264. DNA methylation of multiple genes in gastric carcinoma: Association with histological type and CpG island methylator phenotype, CANCER SCIENCE, 94(10), 901-905, 200310
  265. The promoter methylation status of the DNA repair gene O-6-methylguanine-DNA methyltransferase in ulcerative colitis, VIRCHOWS ARCHIV, 443(4), 518-523, 200310
  266. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan, INTERNATIONAL JOURNAL OF ONCOLOGY, 23(2), 421-427, 200308
  267. DNA hypermethylation and histone hypoacetylation of the HLTF gene are associated with reduced expression in gastric carcinoma, CANCER SCIENCE, 94(8), 692-698, 200308
  268. Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma, VIRCHOWS ARCHIV, 443(2), 146-151, 200308
  269. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma, VIRCHOWS ARCHIV, 442(6), 563-568, 200306
  270. Expression of theTSP-1 gene and its association with promoter hypermethylation in gastric carcinomas, ONCOLOGY, 64, 423-429, 20030401
  271. Histone acetylation and gastrointestinal carcinogenesis, ANN NY ACADEMY OF SCIENCE, 983, 220-231, 20030401
  272. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 22(4), 773-778, 200304
  273. Molecular targeting therapy for cancer: the twelfth international symposium of the Hiroshima cancer seminar November 2002, CANCER SCIENCE, 94(2), 221-223, 20030201
  274. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma, VIRCHOWS ARCHIV, 442(2), 118-123, 200302
  275. A possible role for the loss of CD27-CD70 interaction in myelomagenesis, BRITISH JOURNAL OF HAEMATOLOGY, 120(2), 223-234, 200301
  276. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells, ANTICANCER RESEARCH, 23(1A), 267-273, 2003
  277. Helicobactor pylori infection is closely associated with telomere reduction in gastric mucosa, ONCOLOGY, 65(3), 275-282, 2003
  278. Reduced expression of the TSP1 gene and its association with promoter hypermethylation in gastric carcinoma, ONCOLOGY, 64(4), 423-429, 2003
  279. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas, INTERNATIONAL JOURNAL OF CANCER, 102(3), 220-224, 20021120
  280. Acetylated histone h4 is reduced in human gastric adenomas and carcinomas, JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 21(3), 377-382, 200209
  281. Distinct promoter hypermethylation of p16(INK4a), CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas, JOURNAL OF PATHOLOGY, 198(1), 55-59, 200209
  282. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa, EUROPEAN JOURNAL OF CANCER, 38(10), 1413-1419, 200207
  283. Increased expression of Chk2 in human gastric carcinomas harboring p53 mutations, INTERNATIONAL JOURNAL OF CANCER, 99(1), 58-62, 20020501
  284. Chromatin and Cancer: The eleventh international symposium of the Hiroshima Cancer Seminar., JAPANESE JOURNAL OF CANCER RESEARCH, 93, 467-469, 20020401
  285. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer, JOURNAL OF PATHOLOGY, 196(2), 163-170, 200202
  286. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues, ANTICANCER RESEARCH, 22(6C), 4101-4107, 2002
  287. No mutations of the Bub1 gene in human gastric and oral cancer cell lines, ONCOLOGY REPORTS, 9(6), 1229-1232, 2002
  288. Induction of hRAD9 is required for G2/M checkpoint signal transduction in gastric cancer cells, PATHOBIOLOGY, 70(1), 40-46, 2002
  289. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3, CLINICAL CANCER RESEARCH, 7(12), 4067-4072, 200112
  290. Pleomorphic adenoma of the parotid gland with extensive bone formation, PATHOLOGY INTERNATIONAL, 51(11), 883-886, 200111
  291. Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells, PROSTATE, 49(1), 19-29, 20010915
  292. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 93(6), 805-809, 20010915
  293. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas, INTERNATIONAL JOURNAL OF CANCER, 93(5), 662-666, 20010901
  294. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 19(3), 507-512, 200109
  295. Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer, DIFFERENTIATION, 68(1), 13-21, 200108
  296. Epithelial-myoepithelial carcinoma of the parotid gland with adenoid cystic carcinoma-like features: a case report with immunohistochemical study, Hiroshima J. Med. Sci., 50, 101-104, 20010401
  297. Expression of TRF1 (telomeric repeat binding factor 1 and 2) and TIN2 (TRF1-interacting nuclear protein 2) in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 507-512, 20010401
  298. Meeting Report"Gene Diagnosis-Introduction of New Technology" : The Tenth International Symposium of the Hiroshima Cancer Seminar, October 2000(共著), JAPANESE JOURNAL OF CANCER RESEARCH, 92, 239-242, 20010401
  299. Molecular diagnosis of gastric cancer: present and future, GASTRIC CANCER, 4, 113-121, 20010401
  300. Prostpective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis, JOURNAL OF EXPERIMENTAL AND CLINICAL CACER RESEARCH, 20(4), 543-548, 20010401
  301. Proton pump inhibitors reduce cell cycle abnormalities in Barrett’s esophagus, ONCOGENE, 20, 7987-7991, 20010401
  302. The promoter methylation status of the DNA repair genes, hMHL1 and MGMT, in gastric carcinoma and metaplastic mucosa, PATHOBIOLOGY, 69, 143-149, 20010401
  303. Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 92(1), 42-50, 200101
  304. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas, ONCOLOGY REPORTS, 8(5), 1085-1089, 2001
  305. No mutations of the Bub1 gene in human gastric carcinomas, ONCOLOGY REPORTS, 8(4), 791-794, 2001
  306. Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas, PATHOBIOLOGY, 69(1), 24-29, 2001
  307. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas, PATHOBIOLOGY, 69(4), 219-224, 2001
  308. Genetic and epigenetic changes in stomach cancer, INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 204, 204, 49-95, 2001
  309. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas, PATHOBIOLOGY, 69(6), 315-320, 2001
  310. Interleukin-15 expression is associated with malignant potential in colon cancer cells, PATHOBIOLOGY, 69(2), 86-95, 2001
  311. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa, PATHOBIOLOGY, 69(3), 143-149, 2001
  312. Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines, INTERNATIONAL JOURNAL OF CANCER, 88(6), 992-997, 20001215
  313. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer, AMERICAN JOURNAL OF PATHOLOGY, 157(5), 1523-1535, 200011
  314. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues, ONCOGENE, 19(34), 3888-3893, 20000810
  315. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8, CLINICAL CANCER RESEARCH, 6(7), 2735-2740, 200007
  316. Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas, EUROPEAN JOURNAL OF CANCER, 36(8), 1002-1007, 200005
  317. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines, CANCER LETTERS, 151(2), 199-208, 20000414
  318. A case of calcium pyrophosphate dihydrate crystal deposition in the knee joint with synovial osteochondromatosis, JOURNAL OF TRANSPORTATION MEDICINE, 54, 93-96, 20000401
  319. Meeting Report ’Pediatric Tumors and Secondary Cancer. The Ninth International Symposium of the Hiroshima Cancer Seminar, September 1999, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 126, 357-359, 20000401
  320. Trichostatin A inhibits cell growth and modulate expression of cell cycle- and apoptosis-related molecules in human gastric and oral cancer cell lines, INTERNATIONAL JOURNAL OF CANCER, 1, 992-997, 20000401
  321. Helicobactor pylori infection and carcinogenesis of the stomach, LANGENBECKS ARCHIVES OF SURGERY, 385(2), 69-74, 200003
  322. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis, CANCER LETTERS, 149(1-2), 125-134, 20000228
  323. Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: Association with Helicobacter pylori infection, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 5(2), 185-190, 200002
  324. Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus, ANTICANCER RESEARCH, 20(1A), 213-217, 2000
  325. Abnormalities in the expression cell cycle related proteins in tumors of the small bowel, CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, 8, 1101-1105, 19990401
  326. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype, INTERNATIONAL JOURNAL OF CANCER, 83, 192-196, 19990401
  327. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 255, 753-758, 19990401
  328. Evidence for the causal role of IL-8 in angiogenesis and tumorigenecity of human gastric carcinoma cells, BRITISH JOURNAL OF CANCER, 81, 647-653, 19990401
  329. Expression of cell cycle regulating transcription factor E2F-1 in colorectal carcinomas, PATHOBIOLOGY, 67, 174-179, 19990401
  330. Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma, ONCOLOGY REPORTS, 6, 983-987, 19990401
  331. Expression of the E2F family in human gastrointestinal carcinomas, INTERNATIONAL JOURNAL OF CANCER, 81, 535-538, 19990401
  332. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections, ONCOGENE, 18(8), 1561-1567, 19990401
  333. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach, JAPANESE JOURNAL OF CANCER RESEARCH, 90(6), 589-595, 19990401
  334. Meeting Report ’Aging and cancer’. The Eighth International Symposium of the Hiroshima Cancer Seminar, November 1998, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 125, 375-377, 19990401
  335. Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology, PATHOLOGY INTERNATIONAL, 49(9), 763-774, 19990401
  336. No mutations of the Smad2 gene in human sporadic gastric carcinomas, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 29, 3-7, 19990401
  337. Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis, VIRCHOWS ARCHIV, 434, 483-487, 19990401
  338. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues, MOLECULAR CARCINOGENESIS, 26(4), 312-320, 19990401
  339. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 in oral malignant tumors, PATHOBIOLOGY, 67, 169-173, 19990401
  340. Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line, JAPANESE JOURNAL OF CANCER RESEARCH, 90(5), 485-489, 19990401
  341. Subcutaneous leiomyoma arising from the srteriole: case report, JOURNAL OF TRANSPORTATION MEDICINE, 53, 80-82, 19990401
  342. EXPRESION OF THE E2F FAMIRY IN HUMAN GASTROINTEST INAL CARCINOMAS, INTERNATIONAL JOURNAL OF CANCER, 81, 535-538, 19990101
  343. Microsatellite Instability Associated with Primary Head and Neck Cancers and Secondary Esophageal Cancers, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 28(12), 733-739, 19981201
  344. Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions, Eur J Gynaecol Oncol, 19, 316-318, 19980401
  345. Co-expression of osteopontin and CD44v9 in gastric cancer, INTERNATIONAL JOURNAL OF CANCER, 79, 127-132, 19980401
  346. Expression of CD44 containing variant exon 9(CD44v9) in gastric adenomas and adenocarcinomas: Relation to the proliferation and progression., INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 1253-1258, 19980401
  347. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 89(11), 1099-1103, 19980401
  348. Expression of vascular endothelial growth factor in human gastric carcinomas, PATHOLOGY INTERNATIONAL, 48, 499-506, 19980401
  349. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 1245-1251, 19980401
  350. Frequent p53 gene mutations in serrated adenomas of the colorectum, JOURNAL OF PATHOLOGY, 186, 131-139, 19980401
  351. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions, JAPANESE JOURNAL OF CANCER RESEARCH, 89(11), 1187-1194, 19980401
  352. Meeting Report ’Gene therapy : Application to disease’. The Seventh International Symposium of the Hiroshima Cancer Seminar, November 1997, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 124, 285-287, 19980401
  353. nm23 expression in carcinoma of the uterine cervix, Eur J Gynaecol Oncol, 19, 312-315, 19980401
  354. nm23 protein expression in renal cell tumors: the role of the cell type, ONCOLOGY REPORTS, 5, 979-983, 19980401
  355. Reduced Expression of Cyclin-dependent Kinase Inhibitor p27Kip1 is an Indicator of Malignant Behavior of Oral Squamous Cell Carcinomas, CANCER, 83, 2447-2466, 19980401
  356. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis, JOURNAL OF ORAL APTHOLOGY AND MEDICINE, 27, 197-201, 19980401
  357. Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers, JOURNAL OF CLINICAL PATHOLOGY, 50, 841-846, 19970401
  358. Expression of human telomerase RNA is an early event of stomach carcinogenesis, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 103-107, 19970401
  359. Expression of Interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 953-958, 19970401
  360. Expression of p21WAF1/CIP1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. 「(共著)」, PATHOLOGY INTERNATIONAL, 47, 470-477, 19970401
  361. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein, DIFFERENTIATION, 61, 313-320, 19970401
  362. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27(Kip1) in a human gastric carcinoma cell line, CELL GROWTH AND DIFFERENTIATION, 8(1), 47-52, 19970401
  363. Growth stimulatory effect of interleukin (IL)-1a produced by oral squamous carcinoma cell lines., INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 807-812, 19970401
  364. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 genes in Japanese hereditary nonpolyposis colorectal cancer kindreds, CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, 6, 1057-1064, 19970401
  365. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa, Digestive Diseases Sci, 42, 1199-1209, 19970401
  366. Overexpression of CDK-activating CDC25B phosphatase in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 947-952, 19970401
  367. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 625-629, 19970401
  368. A case of hepatoblastoma in an adult associated with c-met proto-oncogene imbalance, PATHOLOGY INTERNATIONAL, 46, 1005-1010, 19960401
  369. Expression of cripto in human gall bladder lesions, JOURNAL OF PATHOLOGY, 180, 166-168, 19960401
  370. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines, JOURNAL OF EXPERIMENTAL AND THERAPEUTIC ONCOLOGY, 1, 7-12, 19960401
  371. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein, VIRCHOWS ARCHIV, 429, 13-19, 19960401
  372. Expression of cyclin E in human gastric adenomas and adenocarcinomas: Correlation with proliferative activity and p53 status, JOURNAL OF EXPERIMENTAL AND THERAPEUTIC ONCOLOGY, 1, 88-94, 19960401
  373. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach : Relation with p53 status and proliferative activity, JOURNAL OF PATHOLOGY, 180, 122-128, 19960401
  374. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 87(8), 824-830, 19960401
  375. High frequency of p53 gene mutations in adenocarcinomas of the gallbladder, CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, 5, 461-466, 19960401
  376. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells, JAPANESE JOURNAL OF CANCER RESEARCH, 87(4), 377-384, 19960401
  377. Meeting Report ’Telomerase and cancer. The Fifth International Symposium of Hiroshima Cancer Seminar, October 1995, Hiroshima, Japan’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 122, 770-773, 19960401
  378. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach, CANCER, 77/8S, 1620-1627, 19960401
  379. Molecular diagnosis of gastrointestinal cancers: The applications to clinical practice, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 1, 63-68, 19960401
  380. No point mutations but a codon 31 polymorphism and decreased expression of p21SDI1/WAF1/CIP1/MDA6 gene in human gastric carcinomas, MOLECULAR AND CELLULAR DIFFERENTIATION, 4, 187-198, 19960401
  381. Expression of IL-6 and its effect on the cell growth of gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 88, 953-958, 19970401
  382. Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas, VIRCHOWS ARCHIV, 426(4), 355-359, 19950501
  383. A case of fetal epidural hematoma caused by a slight car collision and liability for the fatality, Res. Pract. Forens. Med., 38, 231-234, 19950401
  384. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study, BRITISH JOURNAL OF CANCER, 72, 976-980, 19950401
  385. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas, INTERNATIONAL JOURNAL OF CANCER, 62, 25-28, 19950401
  386. Expression of amphiregulin in human gastric cancer cell lines, CANCER, 75, 1460-1466, 19950401
  387. Expression of Stat91, Ras-independent signal transducer and activator, in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 7, 907-911, 19950401
  388. Frequent amplification of the cycin E gene in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 86, 617-621, 19950401
  389. IL-1αin produced by oral squamous carcinoma cell lines and stimulates their growth, ORAL ONCOLOGY, 4, 324-327, 19950401
  390. Increased expression and posphorylatioln of SH-PTP2 (SYP) in human gastric carcinolmas, ONCOLOGY REPORTS, 2, 819-823, 19950401
  391. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions, CLINICAL CANCER RESEARCH, 1(11), 1245-1251, 19950401
  392. Alterations and expression of bcl-2 gene in human gastric and colonic carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 85, 584-591, 19940401
  393. Coamplification of cyclin D, hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas., ONCOLOGY REPORTS, 1, 493-496, 19940401
  394. Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines, VIRCHOWS ARCHIV, 425, 139-144, 19940401
  395. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 56, 474-480, 19940401
  396. Expression of cripto in human gastric carcinomas : an association with tumor stage and prognosis, JOURNAL OF EXPERIMENTAL AND CLINICAL CACER RESEARCH, 13, 151-157, 19940401
  397. Expression of cripto in human pancreatic tumors, JAPANESE JOURNAL OF CANCER RESEARCH, 85, 118-121, 19940401
  398. Expression of β1 integrin in human gastric carcinomas : correlation with histological type and tumor progression, INTERNATIONAL JOURNAL OF ONCOLOGY, 5, 225-230, 19940401
  399. Frequent loss of heterozygosity of chromosome 7q is closely associated with progression of human gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 59, 597-600, 19940401
  400. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers, CANCER RESEARCH, 54, 3373-3375, 19940401
  401. Gene alterations in intestinal metaplasia and gastric cancer, Eur J Gastroenterol Hepatol, 6, 97-101, 19940401
  402. Meeting Report ’The First International Workshop of the Princess Takamatsu Cancer Research Fund: Intestinal metaplasia and gastric cancer’, MOLECULAR CARCINOGENESIS, 11, 1-7, 19940401
  403. Meeting Report ’Tumor suppressor gene, TheThird International Symposium of Hiroshima Cancer Seminar, Hiroshima, Japan, October 1993’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 120, 615-619, 19940401
  404. A case of death after trichloroethylene sniffing and a fight, Jpn. J Forensic Toxicol., 11, 187-193, 19930401
  405. Aberrant expression of c-met mRNA in human gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 72-75, 19930401
  406. Biologic effect of hepatocyte growth factor on human gastric carcinoma cell lines, INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 89-93, 19930401
  407. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 84, 879-884, 19930401
  408. Expression of growth factors and their receptors in human esophageal carcinomas:regulation of expresion by EGF and TGF-alpha., JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 119, 401-407, 19930401
  409. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression, INTERNATIONAL JOURNAL OF CANCER, 54, 49-52, 19930401
  410. GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines, CELL GROWTH AND DIFFERENTIATION, 4, 291-296, 19930401
  411. IL-1a acts as an autocrine growth stimulator for human gastric carcinoma cells, CANCER RESEARCH, 53, 4102-4106, 19930401
  412. Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas, INTERNATIONAL JOURNAL OF CANCER, 53, 36-41, 19930401
  413. Interleukin 1a acts as an autocrine growth stimulator for human gastric carcinoma cells, CANCER RESEARCH, 53, 4102-4106, 19930401
  414. Meeting Report ’Carcinogenesis and metastasis, The second international symposium of Hiroshima Cancer Seminar, Hiroshima, Japan, June 1992’, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 119, 560-563, 19930401
  415. Occifying fibromyxoid tumor of soft parts : A case report, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 23, 64-68, 19930401
  416. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 84, 184-190, 19930401
  417. Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 63, 213-218, 19930401
  418. Reduced tumorigenicity and cell motility of a gastric carcinoma cell line by introduction of wild-type p53 gene, INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 265-271, 19930401
  419. A serine protease inhibitor of benzamidine derivative inhibits the growth of human colon carcinoma cells, JAPANESE JOURNAL OF CANCER RESEARCH, 83, 723-728, 19920401
  420. Expression of transforming growth factor alpha in human tissue : immunohistochemical study and Northern blot analysis, VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 421, 513-519, 19920401
  421. Frequent amplification and expression of the c-met gene in human scirrhous type stomach cancer, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 189, 227-232, 19920401
  422. Genetic abnormalities and expression of p53 in human colon carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 1, 431-437, 19920401
  423. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells : Receptor and postreceptor signaling, CANCER RESEARCH, 52, 295-300, 19920401
  424. p53 gene mutations in gastric cancer cell lines, ONCOLOGY (Life Sci Adv), 11, 7-12, 19920401
  425. p53 point mutations in primary human gastric carcinomas, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 119, 67-70, 19920401
  426. Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas, JAPANESE JOURNAL OF CANCER RESEARCH, 83, 86-92, 19920401
  427. The level of transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 189, 1342-1348, 19920401
  428. Tyrosine kinase activity of epidermal growth factor receptor in human gastric carcinomas, PATHOLOGY RESEARCH AND PRACTICE, 188, 37-43, 19920401
  429. Effect of tyrosine kinase inhibitor, erbstatin, on cell growth and growth factor/recptor expression in human gastric carcinoma cells, INTERNATIONAL JOURNAL OF CANCER, 47, 938-942, 19910401
  430. Express of cripto a novel gene of the epidermal growth factor family,in human gastrointestinal carcinomas., JAPANESE JOURNAL OF CANCER RESEARCH, 821, 963-973, 19910401
  431. Expression of basic fibroblast growth factor in human gastric carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 61, 263-267, 19910401
  432. Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas, VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 82, 969-973, 19910401
  433. Expression of epidermal growth factor in human tissues : Immunohistochemical and biochemical analysis, VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 418, 27-32, 19910401
  434. Inhibitory effect of 8-Chloro-cyclic adenosine 3',5'-monophosphate on cell growth of gastric carcinoma cell lines, JAPANESE JOURNAL OF CANCER RESEARCH, 82, 325-331, 19910401
  435. Myxoid leiomyosarcoma of the stomach: A case report, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 21, 447-452, 19910401
  436. Depressed tubular adenoma of the stomach: Pathological and immunohisto- chemical properties, HISTOPATHOLOGY, 17, 419-426, 19900401
  437. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 58, 273-277, 19900401
  438. Effect of epidermal growth factor on rat stomach carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine, ACTA PATHOL JPN, 40, 165-171, 19900401
  439. Expression of ERBB2 in human gastric carcinomas : Relationship between p185ERBB2 expression and the gene amplification, CANCER RESEARCH, 50, 8002-8009, 19900401
  440. Expression of several growth factors and their receptor genes in human colon carcinomas, VIRCHOWS ARCHIV B (Cellullar Pathology), 59, 173-178, 19900401
  441. Growth factors in progression of human esophageal and gastric carcinomas, EXPERIMENTAL PATHOLOGY, 291-300, 19900401
  442. pp60c-src protein kinase activity in human gastric carcinomas, INTERNATIONAL JOURNAL OF CANCER, 45, 847-851, 19900401
  443. Characterization of early DNA synthesis in Xenopus eggs after injection of circular plasmid DNA, NUCLEIC ACIDS RESEARCH, 17, 3709-3723, 19890401
  444. Effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1, Hiroshima J. Med. Sci., 38, 191-195, 19890401
  445. Minichromosome assembly accompanying repair-type DNA synthesis in Xenopus oocytes, NUCLEIC ACIDS RESEARCH, 17, 10243-10258, 19890401
  446. Presence of multiple species of polypeptides immunologically related to transcription factor TFIIIA in adult Xenopus tissues, NUCLEIC ACIDS RESEARCH, 17, 5597-5610, 19890401
  447. Quantitation and subcellular localization of proliferating cell nuclear antigen (PCNA/cyclin) on oocytes and eggs of Xenopus laevis, EXPRIMENTAL CELL RESEARCH, 182, 384-393, 19890401
  448. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas, CANCER RESEARCH, 48, 137-141, 19880401
  449. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma, INTERNATIONAL JOURNAL OF CANCER, 41, 211-217, 19880401
  450. Phenotypic expression of human epidermal growth factor in fetal submandibular gland and pleomorphic adenoma of salivary gland., VIRCHOWS ARCHIV A (Pathological Anatomy and Histopathology), 412, 301-306, 19880101
  451. Effects of a protein-free diet on the rat stomach, GASTROENTEROLOGY, 92, 1051-1059, 19870401
  452. Expression of Ha-ras oncogene product in rat gastrointestinal carcinomas induced by chemical carcinogens, ACTA PATHOL JPN, 37, 1731-1741, 19870401
  453. Immunohistochemical detection of c-myc-oncogene product in human gastric carcinomas: Expression in tumor cells and stromal cells, JAPANESE JOURNAL OF CANCER RESEARCH, 78, 1169-1174, 19870401
  454. Cholecystokinin inhibition of tumor growth and gastrin-stimulated cAMP metabolism in human gastric carcinoma in nude mice, CANCER RESEARCH, 46, 740-743, 19860401
  455. Gut endocrine cells in rat stomach carcinoma induced by N-methyl-N’-nitro-N-nitrosoguanidine, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 111, 87-92, 19860401
  456. Ha-ras oncogene product in human gastric carcinoma: Correlation with invasiveness, metastasis or prognosis, JAPANESE JOURNAL OF CANCER RESEARCH, 77, 517-522, 19860401
  457. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy, JAPANESE JOURNAL OF CANCER RESEARCH, 77, 145-152, 19860401
  458. Light and electron microscopic observations of the white pulp of the dog spleen during hemorrhagic shock, PATHOLOGY RESEARCH AND PRACTICE, 181, 586-595, 19860401
  459. Calcium-activated, phospholipid-dependent protein kinase in human gastric mucosa and carcinoma, JAPANESE JOURNAL OF CANCER RESEARCH, 76, 1168-1173, 19850401
  460. Effect of gastrin on gastric mucosal cyclic adenosine 3’:5’-monophosphate- dependent protein kinase activity in rat stomach carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine, CANCER RESEARCH, 45, 4763-4767, 19850401
  461. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1, JAPANESE JOURNAL OF CANCER RESEARCH, 76, 1064-1071, 19850401
  462. Type I and II cyclic adenosine3’:5’-monophosphate-dependent protein kinase in human gastric mucosa and carcinomas, CANCER RESEARCH, 45, 1565-1568, 19850401
  463. Effect of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric carcinoma in nude mice, CANCER RESEARCH, 44, 4276-4280, 19840401
  464. Secretory component and immunoglobulin in human gastric carcinoma: An immunohistochemical studySecretory component and immunoglobulin in human gastric carcinoma: An immunohistochemical study, JAPANESE JOURNAL OF CANCER RESEARCH, 75, 166-176, 19840401

Publications such as books

  1. 2019, Lymph node metastasis in gastrointestinal cancer, Molecular mechanisms of lymph node metastasis, Springer, 2019, English, Oue N, Kitadai Y, Yasui W
  2. 2019/06, WHO Classification of Tumours - 5th Edition, Digestive System Tumours, Gastric adenocarcinoma, International Agency for Research on Cancer, 2019, 6, English, Carneiro F, Fukayama M, Grabsch HI, Yasui W, 978-92-832-4499-8, 635
  3. 2017/02, Standard Text Book PT/OT Pathology 4th ed., 8 Neoplasia, Igakushoin, 2017, 2017, Japanese, 978-4-260-02871-4, 295, 19
  4. 2015/08/15, Simple Pathology 7th ed., Nankodo, 2015, 8, Japanese, Hironobu Sasano, Yasunori Okada, Wataru Yasui, ISBN978-4-524-26154-3C3047, 394, 394
  5. 2014, Atlas of Gastric Cancer Pathology for Clinician, Medical Review Co., 2014, 08, Japanese, Wataru Yasui, Masaki Kitajima, Kazuhiro Yoshida, 143, 143
  6. 2014, Master of Gastric Surgery, Handling of surgically resected specimen in pathology, Medical View Co. Ltd., 2014, 201403, Japanese, Kasuhiro Sentani, 978-4-7583-1514-2 C3047
  7. 2013, Principle of molecular diagnostics and personalized cancer medicine, Lippincott Williams & Wilkins, 2013, Yasui W, Oue N, Sentani K, Tan DF
  8. 2012, Clinical Radiation Oncology, Tumor biology, Nankodo Co., 2012, 201212, 26322-6 C3047
  9. 2012/03, Handbook on Effect of A-bomb Radiation, 2nd ed., Effects on human body, Bunkodo Co. Ltd., 2012, 3, Japanese, 978-4-8306-3741-4 C3047
  10. 2011, Radiation Exposure and Thyroid Cancer - Hiroshima, Chernobyl and Semipalatinsk, Keisuisha Co., 2011, Japanese, Takeishi N, Hosi M, Yasui W, 978-4-86327-152-4 C3047, 141
  11. 2010, Scirrhous Carcinoma of the Stomach - A Multidisciplinary Approach, Genetic alterations in scirrhous type gastric cacner, Ishiyaku Journal Co. Ltd., 2010, 3, Japanese, Wataru Yasui, Junichi Motoshita, Naohide Oue, 978-4-7532-2429-6 C3047
  12. 2010, Atlas - Cytological and Pathological Diagnosis, Igakushoin Co.Ltd., 2010, 6, Japanese, Wataru Yasui, 978-4-260-00941-6 C3047
  13. 2010, Dynamic Pathology, Nishimura Co. Ltd., 2010, 12, Japanese, Nayakama F, Yasui W, 978-4-89013-402-1 C3047
  14. 2009, Histological and serological tumor markers and their clinical usefulness in cancers, Nova Science Publishers, 2009, Yasui W, Sentani K, Sakamoto N, Motoshita J, Oue N
  15. 2007, International Congress Series: Radiation Risk Perspectives , Elsevier Science Publishers, 2007, 05, Yasui W
  16. 2006, Recent advances in molecular pathobiology of gastric carcinoma. , 2006, 04, Yasui W, Oue n, Kitadai Y, Nakayama H, 51
  17. 2005, The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy , Springer-Verlag, 2005, Yasui W, Oue N, Kitadai Y, Nakayama H
  18. 2003, Handbook of Experimental Pharmacology Mechanisms in Carcinogenesis and Cancer Research , Springer-Verlag, 2003, Ohgaki H, Yasui W, Yokota J
  19. 1999, Molecular Pathology of Early Cancer , IOS press, 1999, Yasui W
  20. 1997, Molecular Pathology of Gastrointestinal Cancer -Application to Clinical Practice- , Springer-Verlag, 1997, Yasui W
  21. 1996, Cell Proliferation in Cancer , Oxford University Press, 1996, Yasui W
  22. 1996, The Chernobyl Accident. Thyroid Abnormalities in Children, Congenital Abnormalities and Other Radiation Related Information - The First Ten Years - , Hiroshima-Nagasaki Peace Foundation, 1996, Yasui W
  23. 1994, Gann Monograph on Cancer Research No. 42, Growth factors: cell growth, morphogenesis, and transformation , CRC Press, 1994, Yasui W
  24. 1993, Surgical Gynecologic Oncology , Georg Thime Verlag, 1993, Yasui W
  25. 1993, Gastric Cancer , Springer-Verlag, 1993, Yasui W
  26. 1992, Diagnostic Molecular Pathology Vol. II: A Practical Approach , IRL Press= Oxford University Press, 1992, Yasui W
  27. 1988, Progress in Cancer Research and Therapy, Hormone and Cancer 3 , Raven Press Ltd, 1988, Yasui W

Invited Lecture, Oral Presentation, Poster Presentation

  1. Uc.416+A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma, Sekino Y, Thang PQ, Honma R, Shigematsu Y, Sakamoto N, Sentani K, Oue N, Teishima J, Yasui W and Matsubara A, The 35th Korea-Japan Urological Congress, 2018/12/06, Without Invitation, Okinawa (Japan)
  2. Pitfalls of rapid on site evaluation in endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic tumors (Global Asia Forum), Taniyama D, Kuraoka K, Fujisawa H, Kan A, Yasumura N, Yoshida M, Toda T, Saiki Y, Yamamoto H, Zaitsu J, Saitou A, Yasui W, Taniyama K, 2018/06/01, With Invitation
  3. Expression and biological function of ADAM28 in colorectal adenocarcinoma, Hattori T, Sakamoto N, Horie K, Shimoda M, Ishikawa A, Taniyama D, Honma R, Oue N, Sentani K, Hinoi T, Egi H, Ohdan H, Okada Y, Yasui W., Global Academic Programs conference 2018, 2018/05/15, Without Invitation, Stockholm (Sweden)
  4. Significance of CD204 positive tumor-associated macrophages in malignant transformation of colorectal adenoma., Taniyama D, Taniyama K, Sakamoto N, Sentani K, Oue N, Yamamoto H, Zaitsu J, Saitou A, Kuraoka K, Yasui W, Global Academic Programs conference 2018, 2018/05/15, Without Invitation, Stockholm (Sweden)
  5. Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer., Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Oue N, Sentani K, Teishima J, Yasui W and Matsubara A, 2018/04/19, Without Invitation
  6. BRAFV600E mutation and loss of CDX2 synergize in serrated colorectal tumorigenesis., Sakamoto N, Feng Y, Hattori T, Shimoda M, Ishikawa A, Honma R, Hinoi T, Egi H, Ohdan H, Okada Y, Fearon E and Yasui W, The 109th Annual Meeting of the American Association for Cancer Research, 2018/04/14, Without Invitation, Chicago, Illinois (USA)
  7. Expression analysis of transcribed-ultraconserved regions in cancer stem cell population using colorectal cancer organoids., Honma R, Sakamoto N, Ishikawa A, Taniyama D, Fukada K, Sekino Y, Mukai S, Sentani K, Oue N, Hinoi T, Egi H, Ohdan H and Yasui W, The 109th Annual Meeting of the American Association for Cancer Research, 2018/04/14, Without Invitation, Chicago, Illinois (USA)
  8. Pten haploinsufficiency promotes tumor invasion and carcinogenesis in mouse colon epithelium with Apc deficiency., Sada H, Hinoi T, Niitsu H, Kovhi M, Sakamoto N, Sentani K, Oue N, Yasui W and Ohdan H, The 109th Annual Meeting of the American Association for Cancer Research, 2018/04/14, Without Invitation, Chicago, Illinois (USA)
  9. Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer., Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Oue N, Sentani K, Teishima J, Yasui W and Matsubara A, European Association of Urology Annual Meeting 2018, 2018/03/15, Without Invitation, Copenhagen (Denmark)
  10. Imaging futures of cystic renal lesions in the era of the 2016 WHO classification, Honda Y, Yasui W, Goto K, Hayashi T, Teishima J and Matsubara A, The 103rd Annual Meeting of the Radiological Society of North America 2017, 2017/11/26, Without Invitation, Radiological Society of North America, Chicago, Illinois (USA)
  11. Biological Significance of Transcribed-ultraconserved Regions in Gastric Cancer, Honma R, Goto K, Sakamoto N, Sekino Y, SEntani K, Oue N, Yasui W, The 10th Kure International Medical Forum, 2017/06/13, With Invitation, Kure International Medical Forum, Kure, Hiroshima (Japan)
  12. Functional roles of CaF-derived extracellular vesicles in scirrhous type gastric cancer, Naito Y, Yashiro M, Hirakawa K, Kiyono T, Yasui W and Ochiya T, The 6th Annual Meeting of the International Society of Extracellular Vesicle 2017, 2017/05/18, Without Invitation, International Society of Extracellular Vesicle, Toronto (Canada)
  13. Identification of novel biomarkers and potential therapeutic targets of stomach and prostate cancers., Yasui W, Seminar at Department of Molecular Pathology, University of Texas MD Anderson Cancer Center, 2017/05/11, With Invitation, Department of Molecular Pathology, University of Texas MD Anderson Cancer Center, Texas (USA)
  14. Novel therapeutic strategy targeting nutrient supply of chronic myelogenous leukemia stem cells, Naka K, Takihara Y, Ichinohe T, Hida E, Kato Y, Yasui W and Kim SJ, Global Academic Program 2017 Conference, 2017/05/09, Without Invitation, University of Texas MD Anderson Cancer Center, Houston, Texas (USA)
  15. Colorectal cancer organoid library: a promising screening tool for assessment of chemosensitivity, Sakamoto N, Ishikawa A, Honma R, Hinoi T, Oue N, Sentani K, Mukai S, Egi H, Ohdan H, Yasui W, Global Academic Program 2017 Conference, 2017/05/09, Without Invitation, University of Texas MD Anderson Cancer Center, Houston, Texas (USA)
  16. The value and challenge of HER2 pathways in gastric cancer therapy, Yasui W, Oue N, Sentani K and Sakamoto N, 12th International Gastric Cancer Congress, 2017/04/20, With Invitation, International Gastric Cancer Association, Beijin (China)
  17. Uc.160+ expression and DNA methylation analysis in gastric cancer, Honma R, Goto K, Sekino Y, Sakamoto N, Sentani K, Oue N and Yasui W, 12th International Gastric Cancer Congress, 2017/04/20, Without Invitation, International Gastric Cancer Association, Beijin (China)
  18. Clinicopathological significance of Annexin A10 expression in gastric cancer, Ishikawa A, Sakamoto N, Honma R, Sentani K, Oue N and Yasui W, 12th International Gastric Cancer Congress, 2017/04/20, Without Invitation, International Gastric Cancer Association, Beijin (China)
  19. A colorectal cancer organoid library provides a promising screening tool for assessment of chemosensitivity, Sakamoto N, Ishikawa A, Honma R, Hinoi T, Oue N, Sentani K, Mukai S, Egi H, Ohdan H, Yasui W, Annual meeting of American Association for Cancer Research 2017, 2017/04/01, Without Invitation, American Association of Cancer Research, Washington DC (USA)
  20. Expression of the transcribed ultraconserved region Uc.63+ in prostate cancer, Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Oue N, Sentani K, Teishima J, Matsubara A, Yasui W, Annual meeting of American Association for Cancer Research 2017, 2017/04/01, Without Invitation, American Association for Cancer Research, Washington DC (USA)
  21. Expression and functional analysis of Signal peptidase complex 18 in bladder cancer, Shigematsu Y, Sekino Y, Sakamoto N, Sentani K, Oue N, Hayashi T, Teishima J, Matsubara A, Yasui W, Annual meeting of American Association for Cancer Research 2017, 2017/04/01, Without Invitation, American Association of Cancer Research, Washington DC (USA)
  22. Molecular pathology of gastric cancer in the past, present and future precision medicine, Yausi W, The 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03/08, With Invitation, Japanese Gastric Cancer Association, Hiroshima (Japan)
  23. Search for biomarkers of Stage/III gastric cancer with the goal of personalized therapy, Oshima T, Kimura Y, Miyagi Y, Sakamaki K, Yoshikawa T, Morita S, Yoshida K, Cho H, Shiozawa M, Rino Y, Tsuburaya Y, Sakamoto J, Oue N, Yasui W, Imada T, Masuda M, 2017/03/08, With Invitation
  24. IIntegrin alpha8beta1 promotes tissue fibrosis via differentiation of myofibroblast-a potent therapeutic target on fibrosis, Nishimichi N, Kanno K, Sentani K, Sugiyama A, Ito M, Otani M, Hanaoka M, Yasui W, Yokosaki Y, Gordon Research Conference 2017, 2017/01/29, Without Invitation, Ventura California (USA)
  25. Message from Japanese Gastric Cancer Association - Cross-disciplinary approach to control gastric cancer in precision medicine, Wataru Yasui, The 2016 Annual Congress of Korean Surgical Society, 2016/11/03, With Invitation, Seoul (Korea)
  26. Significance of KIF Genes in Gastric Spheroid Formation, Oue N, Imai T, Yasui W, The 3rd International Forum for Japan and Korea Medical Exchange, 2016/10/15, With Invitation
  27. Molecular pathological appreoach to develop novel cancer diagnostics and therapeutics, Wataru Yasui, The 27th Annual Meeting of the Japanese Society of Oral Pathology, 2016/08/12, With Invitation, Hiroshima (Japan)
  28. Identification of diagnostic and therapeutic targets of gastroesophageal cancer, Wataru Yasui, GAP-related meeting between Hiroshima University and the University of Texas MD Anderson Cancer Center, 2016/07/21, With Invitation, Hiroshima (Japan)
  29. Identification of diagnostic and therapeutic targets of gastroesophageal cancer, Wataru Yasui, GAP-related meeting between Hiroshima University and the University of Texas MD Anderson Cancer Center, 2016/07/21, With Invitation
  30. Molecular Pathology of Gastrointestinal Cancer, Wataru Yasui, Special lecture at Hacettepe University, 2016/02/09, With Invitation, Ankara, Turkey
  31. Molecular pathology of gastric cancer, Wataru Yasui, The 2nd International Forum for Japan and Korea Medical Exchange, 2015/10/17, With Invitation, Kure (Japan)
  32. Pathological diagnosis using a virtual microscope, Taniyama D, Taniyama K, Kuraoka K, Zaitsu J, Saito A, Yasui W, National University Hospital of Singapore – MD Anderson Cancer Center Pathology Update 2015, 2015/10/15, Without Invitation, Singapore (Singapore)
  33. Molecular pathology of gastric cancer, Wataru Yasui, JP Kim Memorial International Gastric Cancer Symposium, 2015/07/31, With Invitation, Seoul, Korea
  34. Endoscopic management of early gastric cancer: Molecular analysis in endoscopic specimen, Wataru Yasui, The 11th International Gastric Cancer Congress, 2015/06, With Invitation, Sao Paulo, Brazil
  35. Functional analysis of extracellular vesicles as a novel regulatory agent of scirrhous type gastric cancer microenvironment, Naito Y, Yashiro M, Hirakawa K, Yasui W, Ochiya T, International Society for Extracellular Vesicles 2015, 2015/04/23, Without Invitation, Washington D.C. (USA)
  36. Significance of KIFC1 in spheroid formation of gastric cancer cells., Oue N, Mukai S, Pham TBT, Sentani K, Yasui W, AACR (American Association for Cancer Research) Annual Meeting 2015, 2015/04/18, Without Invitation, Philadelphia, Pennsylvania (USA)
  37. The expression of FKTN gene in gastric cancer related to radiation exposure: research on atomic bomb survivors, Trang T. Pham, Oue N, Yasui W, AACR (American Association for Cancer Research) Annual Meeting 2015, 2015/04/18, Without Invitation, Philadelphia, Pennsylvania (USA)
  38. Novel biomarkers and therapeutic targets of gastrointestinal cancer identified through transcriptome dissection, Wataru Yasui, The 2nd International Symposium of Hiroshima Research Center for Healthy Ageing, 2015/03, With Invitation, Higashi-Hiroshima
  39. Molecular pathology of cancer cell growth and progression in gastrointestinal cancer, Wataru Yasui, 2015 International Symposium on Tissue Microenvironmental Modulators, 2015/03, With Invitation, Tokyo, Japan
  40. The expression of FKTN gene in gastric cancer related to radiation exposure: research on atomic bomb survivors, Pham TBT, Oo HZ, Sentani K, Oue N, Yasui W, The 4th International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2015/02/14, Without Invitation, Hiroshima
  41. Molecular Pathology of Gastrointestinal Cancer: Identification of novel biomarkers through transcriptome dissection, Wataru Yasui, Special lecture at Federation of Turkish Pathology and Ankara Pathology Society, 2015/02/11, With Invitation, Ankara, Turkey
  42. Relation of Inflammation and neoangiogenesis of epicardial adipose tissue to coronary atherosclerosis based on computed tomography analysis, Tsushima H, Kitagawa T, Yamamoto H, Sentani K, Yasui W and Kihara Y, Scientific Sessions 2014 of American Heart Association, 2014/11/15, Without Invitation, Chicago, Illinoi (USA)
  43. Sulindac delayed and suppressed tumor progression in a human colorectal cancer mouse model (CPC;APC mouse), Adachi T, Hinoi T, Sasaki Y, Shimomura M, Saito Y, Miguchi M, Niitsu H, Kouchi M, Oue N, Yasui W and Ohdan H, The 8th International Conference of the International Society of Gastroenterological Carcinogenesis, 2014/11/13, With Invitation
  44. Significance of spheroid formation associated genes in gastric cancer, Oue N, Mukai S, Trang Pham TB, Sentani K, Yasui W, The 8th International Conference of the International Society of Gastroenterological Carcinogenesis, 2014/11/13, With Invitation
  45. Fukutin, identified by Escherichia coli Ampicillin Secretion Trap (CAST) method, participates in tumor progression in gastric cancer, Sentani K, Oo HZ, Shinmei S, Mukai S, Sakamoto N, Naito Y, Goto K, Hattori Y, Uraoka N, Oue N and Yasui W, The 5th Taiwan-Japan Conjoint Slide Conference of IAP, 2014/10/25, Without Invitation, Taipei (Taiwan)
  46. Novel biomarkers and therapeutic targets for gastric cancer, Wataru Yasui, The 7th Annual Scientific Meeting of the Singapore Gastric Cancer Consortium, 2014/07, With Invitation, Singapore
  47. Regenerating islet-derived family, member 4 enhances cell proliferation, castration-resistance, and chemoresistance through acceleration of neuroendocrine differentiation in human prostate cancer cells., Teishima J, Shoji K, Goto K, Ryoken Y, Shikuma H, Nagatsuma H, Shinmei S, Kitano H, Ohara S, Hayashi T, Oue N, Yasui W and Matsubara A, Annual Meeting of the American Urological Association 2014,, 2014/05/16, Without Invitation, Orland, Florida (USA)
  48. Regenerating islet-derived family, member 4 enhances cell proliferation, castration-resistance, and chemoresistance through acceleration of neuroendocrine differentiation in human prostate cancer cells, Teishima J, Shoji K, Goto K, Ryoken Y, Shikuma H, Nagatsuma H, Shinmei S, Kitano H, Ohara S, Hayashi T, Oue N, Yasui W and Matsubara A, 29th Annual Congress of the European Association of Urology, 2014/04/11, Without Invitation, Stockholm (Sweden)
  49. Sulindac delayed and suppressed the tumor progression, was not effective on inhibition of tumor initiation in a human colorectal cancer mouse model (CPC;Apc mouse), Adachi T, Hinoi T, Sasaki Y, Shimomura M, Saito Y, Miguchi M, Niitsu H, Sotomura Y, Oue N, Yasui W and Ohdan H, The 105th Annual Meeting of the American Association for Cancer Research, 2014/04/05, Without Invitation, San Diego, California (USA)
  50. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intrsepithelial lesion, Sakane J, Taniyama K, Miyamoto K, Sentani K, Oue N and Yasui W, The 105th Annual Meeting of the American Association for Cancer Research, 2014/04/05, Without Invitation, San Diego, California (USA)
  51. The utility of microRNA expression as a potential marker for radiation-associated gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani Km Oue N and Yasui W, The 3rd International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2014/02/15, Without Invitation, Hiroshima
  52. Identification of ZDHHC14 by CAST method and its significance in scirrhous-type gastric cancer, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Oshima T, Yanagihara K and Yasui W, The 3rd International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2014/02/15, Without Invitation, Hiroshima
  53. Relationship between FKTN gene expression in gastric cancer and radiation exposure of atomic bomb survivors, Pham TBT, Oo HZ, Sentani K, Hattori T, Mukai S, Uraoka N, Oue N and Yasui W, The 3rd International Symposium of Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2014/02/15, Without Invitation, Hiroshima (Japan)
  54. ZDHHC14, identified by CAST method, is a putative regulator for peritoneal dissemination of scirrhous-type gastric cancer, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Oshima T, Yanagihara K, Yasui W, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  55. Role of microRNA-143 and its potential of prognostic factor in scirrhous type gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani K, Oue N and Yasui W, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  56. Search for biomarkers of stage II/III gastric cancer and development of individualized therapy, Oshima T, Sakamoto N, Yasui W, Yoshikawa T, Rino Y, Kunisaki C, Imada T and Masuda M, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  57. Combining molecular target drugs to inhibit cancer-stromal cell interaction in gastric cancer, Onoyama M, Kitadai Y, Tanaka Y, Yuge R, Shinagawa K, Tanaka S, Yasui W and Chayama K, The 4th JCA-AACR Special Joint Conference, Urayasu, 2013/12/16, Without Invitation, Chiba (Japan)
  58. Novel biomarkers and therapeutic targets of gastric cancer, Wataru Yasui, The 4th JCA-AACR Special Joint Conference: The Latest Advances in Gastric Cancer Research, 2013/12, With Invitation, Chiba (Japan)
  59. Expression analysis of novel biomarkers identified by Escherichia coli ampicillin secretion trap: Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer, Goto K, Hayashi T, Shinmei S, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A and Yasui W, The 33rd Congress of the International Society of Urology, 2013/09/08, Without Invitation, Vancouver (Canada)
  60. A possible therapeutic agent for pulmonary fibrosis: antibody against integrin a8b1, Nishimichi N, Sentani K, Kanno K, Yausi W and Yokosaki Y, European Respiratory Society Annual Meeting 2013, 2013/09/07, Without Invitation, Barcelona (Spain)
  61. miR-148a, down-regulated in gastric cancer, targets MMP7 and participates in tumor invasion and poor prognosis, Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oo HZ, Yanagihara K, Aoyagi K, Sasaki H and Yasui W, 10th International Gastric Cancer Congress, 2013/06/19, Without Invitation, Verona (Italy)
  62. Imada T and Masuda M: Search for biomarkers of stage II/III gastric cancer and development of individualized therapy, Oshima T, Sakamoto N, Sato T, Cho H, Yukawa N, Yoshikawa T, Rino Y, Kunisaki C, Yasui W, 10th International Gastric Cancer Congress, 2013/06/19, Without Invitation, Verona (Italy)
  63. HP and carcinogenesis -Pathogenesis and novel diagnostic and therapeutic targets, Yasui W, 10th International Gastric Cancer Congress, 2013/06/19, With Invitation
  64. HP and carcinogenesis -Pathogenesis and novel diagnostic and therapeutic targets, Wataru Yasui, 10th International Gastric Cancer Congress, 2013/06, With Invitation, Verona, Italy
  65. TSPAN8 expression in renal cell carcinoma is a poor prognostic factor and a novel therapeutic target, Hayashi T, Sentani K, Black PC, Goto K, Shinmei S, Teishima J, Anami K, Yasui W and Matsubara A, Annual Meeting of the American Urological Association 2013, 2013/05/04, Without Invitation, San Diego, California (USA)
  66. Search for biomarkers of stage II/III gastric cancer and development of individualized therapy, Oshima T, Sakamoto N, Yoshikawa T, Rino Y, Kunisaki C, Yasui W, Imada T and Masuda M, 2013 ASCO Annual Meeting, 2013/04/31, Without Invitation, Chicago, Illinois (USA)
  67. SEC11A contributes to malignant progression through promotion of EGF and TGF-alpha secretion, Oue N, Hayashi T, Takigahara M, Nagatsuma A, Sentani K, Sakamoto N, Anami K, Uraoka N, Naito Y, Yanagihara K, Ochiai A, Sasaki H and Yasui W, The 104th Annual Meeting of the American Association for Cancer Research, 2013/04/06, Without Invitation, Washington D.C., Maryland (USA)
  68. ZDHHC14, a potential regulator of peritoneal dissemination of scirrhous type gastric carcinoma, identified by CAST method, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Yanagihara K and Yasui W, The 104th Annual Meeting of the American Association for Cancer Research, 2013/04/06, Without Invitation, Washington D.C., Maryland (USA)
  69. Novel Biomarkers and therapeutic targets of scirrhous type stomach cancer, Wataru Yasui, Commemorative Symposium for the 2nd anniversary of SNUCH, 2013/04, With Invitation, Seoul, Korea
  70. Differential expression and identification of novel genes in scirrhous type gastric cancer, by CAST method, Oo HZ, Sakamoto N, Uraoka N, Anami K, Sentani K, Oue N, Yanagihara K and Yasui W, The 2nd International Symposium Phoenix Leader Education Program (Hiroshima Initiative) for Renaissance from Radiation Disaster, 2013/02/11, Without Invitation, Hiroshima (Japan)
  71. The utility of miR-143/miR-145 cluster as a potential marker for radiation-associated gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani K, Oue N and Yasui W, The 2nd International Symposium Phoenix Leader Education Program for Renaissance from Radiation Disaster, 2013/02/10, Without Invitation, Hiroshima (Japan)
  72. Function of microRNA-143 and its potential of prognostic factor in scirrhous type gastric cancer, Naito Y, Sakamoto N, Uraoka N, Sentani K, Oue N, Yashiro M, Hirakawa K and Yasui W, The 104th Annual Meeting of the American Association for Cancer Research, 2013/01/06, Without Invitation, Washington D.C., Maryland (USA)
  73. Novel biomarkers of gastric cancer identified by SAGE data analysis, Wataru Yasui, Korea-Japan Cancer Workshop on Gastric Cancer and Liver Cancer, 2012/11, With Invitation, Busan, Korea
  74. Molecular targets for diagnosis and therapeutics of gastric cancer - Present and future, Wataru Yasui, The 17th Japan-Korea Cancer Research Workshop, 2012/11, With Invitation, Busan, Korea
  75. Molecular pathology of gastric cancer - microRNA and novel diagnostic & therapeutic targets, Wataru Yasui, The 96th Annual Meeting of the German Society of Pathology, 2012/05, With Invitation, Berlin, Germany
  76. Transcriptome analysis of esophageal squamous cell carcinoma by SAGE identifies a new biomarker, NRD1, Uraoka N, Sakamoto N, Oue N, Sentani K, Anami K, Noguchi T, Yoshida K and Yasui W, The 103rd Annual Meeting of the American Association for Cancer Research, 2012/03/31, Without Invitation, Chicago, Illinois (USA)
  77. Mir-148a, down-regulated in gastric cancer, targets MMP and participates in tumor invasion, Sakamoto N, Naito Y, Sentani K, Oue N and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  78. Identification of transmembrane protein in scirrhous type gastric cancer by the Escherichia coli ampicillin secretion trap method, Oo HZ, Sakamoto N, Anami K, Wakamatsu Y, Naito Y, Uraoka N, Sentani K, Oue N and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  79. Upregulation of HOX10 in intestinal phenotype gastric cancer: Reduction during tumor progression and favorable prognosis, Sentani K, Oue N, Sakamoto N, Naito Y, Anami K, Oo HZ, Uraoka N and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  80. Analysis of a novel transcriptional target: Reg IV is regulated by CDX2, Naito Y, Oue N, Sentani K, Sakamoto N, Anami K, Hayashi T, Uraoka N, Oo HZ and Yasui W, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11/06, Without Invitation, Hiroshima (Japan)
  81. Molecular characteristics of gastric and intestinal phenotypes of gastric cancer, Wataru Yasui, The 21st International Symposium of the Hiroshima Cancer Seminar, 2011/11, With Invitation, Hiroshima (Japan)
  82. Gene expression profile of scirrhous type gastric cancer analyzed by CAST method, Oo HZ, Uraoka N, Hayashi T, Anami K, Sakamoto N, Sentani K, Oue N and Yasui W, 8th International Symposium on Minimal Residual Cancer, 2011/09/21, Without Invitation, Osaka (Japan)
  83. Overexpression of SEC11A is associated with tumor progression through TGF-alpha secretion in gastric cancer, Oue N, Yanagihara K, Anami K, Sentani K, Sakamoto N, Naito Y and Yasui W, 8th International Symposium on Minimal Residual Cancer, 2011/09/21, Without Invitation, Osaka (Japan)
  84. Epigenetic alterations in colorectal cancer among atomic-bomb survivors, Ito R, Eguchi H, Hamatani K, Taga M, Oue N, Yasui W, Nakachi K and Kusunoki Y, Second AACR International Conference on Frontiers in Basic Cancer Research, 2011/09/14, Without Invitation, San Francisco, California (USA)
  85. Identification of novel diagnostic and therapeutic targets of gastric cancer by transcriptome dissection, Wataru Yasui, The Third CREAST - SBM International Conference "Mathematical Methods in Cancer Cell Biology", 2011/06, With Invitation, Hiroshima (Japan)
  86. Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion, Hayashi T, Ohara S, Shoji K, Teishima J, Anami K, Sakamoto N, Sentani K, Oue N, Yasui W and Matsubara A, The 2011 Annual Meeting of the American Urological Association, 2011/05/14, Without Invitation, Washington D.C. (USA)
  87. DSC2 is a new immunohistochemical marker indicative of squamous cell carcinoma component in urinary bladder cancer and a value of prognostic factor, Hayashi T, Ohara S, Shoji K, Teishima J, Anami K, Sakamoto N, Sentani K, Oue N, Yasui W and Matsubara A, The 2011 Annual Meeting of the American Urological Association, 2011/05/14, Without Invitation, Washington D.C. (USA)
  88. OLFM4 -a bacterial induced epithelial peptide in IBD downstream of Notch, Gersemann M, Becker S, Liu W, Oue N, Yasui W, Rodgers GP, Wehkamp J and Stange EF, Digestive Disease Week (DDW) 2011, 2011/05/07, Without Invitation, Chicago, Illinois (USA)
  89. Canonical Wnt signals promote intestinal stem cell proliferation in the native human colonic epithelium, Parris A, Scobioala-laker N, Reynolds A, Bigwood L, Mitchell EM, Lewis MP, Speakman CT, Wharton R, Hernon J, Sargen K, Kapur S, Oue N, Yasui W and Williams M, Digestive Disease Week (DDW) 2011, 2011/05/07, Without Invitation, Chicago, Illinois (USA)
  90. Compromised tissue renewal in the ageing human colonic epithelium., Mitchell EM, Parris A, Bigwood L, Scobioala-laker N, Reynolds A, Lewis MP, Leung W, Belshaw N, Johnson IT, Oue N, Yasui W, Beals I, Jamieson CP, Tremelling M, Tighe R, Prior A and Williams M, Digestive Disease Week (DDW) 2011, 2011/05/07, Without Invitation, Chicago, Illinois (USA)
  91. Gene expression profile in scirrhous type gastric mcancer by CAST method, Oo HZ, Uraoka N, Hayashi T, Anami K, Sakamoto N, Sentani K, Oue N and Yasui W, 9th International Gastric Cancer Congress, 2011/04/20, Without Invitation, Seoul (Korea)
  92. microRNA expression profiles in gastric cancer: miR-148a is down-regulated in gastric cancer and involved in gastric cancer invasion by repression of MMP7 expression, Sakamoto N, Naito Y, Uraoka N, Anami K, Sentani K, Oue N and Yasui W, 9th International Gastric Cancer Congress, 2011/04/20, Without Invitation, Seoul (Korea)
  93. Unique microRNA signatures associated with progression and prognosis of gastric cancer, Ueda T, Yasui W, Yoshida K, Sasaki S, Nomura S, Seto Y, Kaminishi M, Calin G, Croce C, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu C and Oue N, 9th International Gastric Cancer Congress,, 2011/04/20, Without Invitation, Seoul (Korea)
  94. DSC2 is a new immunohistochemical marker indicative of squamous cell carcinoma component in urinary bladder cancer and a value of prognostic factor, Hayashi T, Ohara S, Shoji K, Teishima J, Anami K, Sakamoto N, Sentani K, Oue N, Yasui W and Matsubara A, The 26th Annual Congress of the European Association of Urolo, 2011/04/02, Without Invitation, Vienna (Austria)
  95. Transcriptional regulation of REG4, a novel diagnostic marker of gastrointestinal cancer by CDX2, Naito Y, Oue N, Sentani K, Sakamoto N, Anami K, Hayashi T, Uraoka N, Oo HZ, Wakamatsu Y and Yasui W, The 102nd Annual Meeting of the American Association for Cancer Research, 2011/04/02, Without Invitation, Orland, Florida (USA)
  96. Blockade of PDFR signaling impairs the tumor promoting effect of bone marrow-derived mesenchymal stem cell in colon cancer., Shinagawa K, Kitadai Y, Ohnishi M, Ohara E, Tanaka M, Sumida T, Tanaka S, Yasui W and Chayama K, The 102nd Annual Meeting of the American Association for Cancer Research, 2011/04/02, Without Invitation, Orland, Florida (USA)
  97. Novel diagnostic and therapeutic targets of gastric cancer identified by "Omics" study, Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y and Oue N, 9th International Gastric Cancer Congress, 2011/04, With Invitation, Seoul (Korea)
  98. OLFM4 -a bacterial induced epithelial peptide in IBD downstream of Notch, Gersemann M, Becker S, Liu W, Oue N, Yasui W, Rodgers GP, Wehkamp J, Stange EF, 6th Congress of European Crohn's and Colitis Organization, 2011/02/24, Without Invitation, Dublin (UK)
  99. Analyses of novel genes encoding secreted and transmembrane proteins identified by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion, Hayashi T, Ohara S, Teishima J, Shoji K, Sentani K, Oue N, Yasui W and Matsubara A, Advancements in Urology 2011 an AUA/JUA Symposium, 2011/02/17, Without Invitation, Hawaii (USA)
  100. Molecular character of gastric and intestinal phenotypes of gastric cancer, Wataru Yasui, The 6th International Conference on Gastroenterological Carcinogenesis, 2011/01, With Invitation, Houston, USA
  101. Vessels constituting benign vascular lesions except arteriovenous hemangiomas lack vascular adventitial fibroblastic cells, Nakayama H, Enzan H and Yasui W, 56th Special Meeting of the Japanese Society of Pathology, International Poster Session, 2010/11/25, Without Invitation, Kokura (Japan)
  102. Mammary mucinous cystadenocarcinoma with ductal carcinoma in situ, Sentani K, Uraoka N and Yasui W, The 20th International Symposium of the Hiroshima Cancer Seminar, 2010/10/31, Without Invitation, Hiroshima (Japan)
  103. A study of central nervous system tumors by histological type in the Hiroshima Prefecture Tumor Registry, Tachiyama Y, Nishi N, Sugiyama H, Ozasa K, Arita K, Kamada N, Kajihara H and Yasui W, 32nd Annual Meeting of International Association of Cancer Registries, 2010/10/12, Without Invitation, Yokohama (Japan)
  104. Novel diagnostic and therapeutic targets of gastrointestinal cancer identified by Omics study, Wataru Yasui, The 9th International Conference of the Asian Clinical Oncology Society, 2010/08, With Invitation, Gifu (Japan)
  105. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis, Sentani K, Matsuda M, Anami K, Sakamoto N, Oue N and Yasui W, The 198th Scientific Meeting of the Pathological Society of Great Britain & Ireland, 2010/06/29, Without Invitation, St Andrews (Scotland), UK
  106. Molecular basis of intestinal and gastric phenotypes of gastric cancer, Wataru Yasui, The 17th Seoul International Cancer Symposium, 2010/06, With Invitation, Seoul (Korea)
  107. Analyses of novel genes necoding secreted and transmembrane proteins identified by CAST method: Cdon is highly expressed in prostate cancer, Hayashi T, Oue N, Anami K, Sakamoto N, Sentani K, Ohara S, Teishima J, Matsubara A and Yasui W, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  108. Desmocollin 2 (DSC2), identified by CAST method, is associated with intestinal phenotype of gastric cancer, Anami K, Oue N, Sakamoto N, Hayashi T, Ohara S, Sentani K, Noguchi T and Yasui W, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  109. Serial Analysis of gene expression (SAGE) of esophageal squamous cell carcinoma: ADAMTS-16 is up-regulated in esophageal squamous cell carcinoma, Sakamoto N, Oue N, Noguchi T, Sentani K, Anami K, Sanada Y, Yoshida K and Yasui W, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  110. Inhibition of platelet derived growth factor receptor tyrosine kinase reduces lymphangiogenesis of human gastrointestinal cancer., Kodama M, Kitadai Y, Sumida T, Ohnishi M, Ohara E, Shinagawa K, Tanaka M, Tanaka S, Yasui W and Chayama K, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C., Maryland (USA)
  111. Inhibition of platelet-derived growth factor receptor tyrosine kinase reduces tumor growth and metastasis in an orthotopic nude mice model of human gastric cancer, Sumida T, Kitadai Y, Ohnishi M, Ohara E, Shinagawa K, Tanaka M, Kodama M, Tanaka S, Yasui W and Chayama K, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C. (USA)
  112. CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium, Takakura Y, Hinoi T, Oue N, Sasada T, Kawaguchi Y, Okajima M, Yasui W and Ohdan H, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C. (USA)
  113. Significance of mesenchymal stem cells in growth and metastasis of colon cancer, Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Tanaka S, Yasui W and Chayama K, The 101st Annual Meeting of the American Association for Cancer Research, 2010/04/17, Without Invitation, Washington D.C. (USA)
  114. Usefulness of Reg IV and claudin-18 immunostaining in the diagnosis of gastrointestinal signet ring cell carcinoma, Sentani K, Oue N, Anami K and Yasui W, 8th International Gastric Cancer Congress, 2009/06/10, Without Invitation, Krakow (Poland)
  115. Identification of novel genes encoding secretory and transmembrane protein in gastric cancer using CAST method, Anami K, Oue N, Sakamoto N, Hayashi T, Ohara S, Motoshita J, Noguchi T and Yasui W, 8th International Gastric Cancer Congress, 2009/06/10, Without Invitation, Krakow (Poland)
  116. Identification of potential therapeutic targets in gastric cancer by basic and translational research-state of art lecture-, Wataru Yasui, 8th International Gastric Cancer Congress, 2009/06, With Invitation, Krakow (Poland)
  117. Olfactomedin 4 in combination with Reg IV have utility in the early detection of gastric cancer, Oue N, Sentani K, Sakamoto N, Noguchi T, Ito R and Yasui W, The 100th Annual Meeting of the American Association for Cancer Research, 2009/04/18, Without Invitation, Denver, Colorado (USA)
  118. Reg IV expression in cancer of the prostate, kidney, and urinary tract: frequent expression of Reg IV in prostate cancer, Ohara S, Ito R, Oue N, Hayashi T, Matsubara A and Yasui W, The 100th Annual Meeting of the American Association for Cancer Research, 2009/04/18, Without Invitation, Denver, Colorado (USA)
  119. Reg IV and claudin-18 are novel markers in the diagnosis of gastrointestinal signet ring cell carcinoma, Sentani K, Oue N, Sakamoto N, Taniyama K and Yasui W, The 18th International Symposium of the Hiroshima Cancer Seminar, 2008/11/09, Without Invitation, Hiroshima (Japan)
  120. Novel biomarkers identified through SAGE data analysis in colorectal cancer, Wataru Yasui, The 18th International Symposium of the Hiroshima Cancer Seminar, 2008/11, With Invitation, Hiroshima (Japan)
  121. Olfactomedin 4 and Reg IV: Novel serum biomarkers for gastric cancer patients, Oue N, Sentani K, Sakamoto N, Noguchi T and Yasui W, 36th Congress of the International Society of Oncology and Biomarkers, 2008/10/05, Without Invitation, Tokyo (Japan)
  122. Immunohistochemical analysis and serum concentration of Reg IV in patients with esophageal cancer, Anami K, Oue N, Sentani K, Sakamoto N, Noguchi T and Yasui W, 36th Congress of the International Society of Oncology and Biomarkers, 2008/10/05, Without Invitation, Tokyo (Japan)
  123. Novel biomarker of gastrointestinal cancers identified by Transcriptome Dissection, Yasui W, Oue N, Sentani K, and Sakamoto N, The 5th International Conference on Gastroenterological Carcinogenesis, 2008/09, With Invitation, Oxford (UK)
  124. The correlation between LI-cadherin and EGFR in gastric cancer, Sakamoto N, Oue N, Sentani K and Yasui W, The 5th International Conference on Gastroenterological Carcinogenesis, 2008/08/31, Without Invitation, Oxford (UK)
  125. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for gastric hepatoid carcinoma, Sentani K, Oue N, Sakamoto N and Yasui W, The 5th International Conference on Gastroenterological Carcinogenesis, 2008/08/31, Without Invitation, Oxford (UK)
  126. Recent Topics: Molecular Pathobiology of gastric cancer, Wataru Yasui, The 8th Korea-Japan Gastrointestinal Pathology Seminar, 2008/02, With Invitation, Yokohama (Japan)
  127. Serum Concentration of Reg IV in patients with colorectal cancers, Oue N, Sentani K, Sakamoto N and Yasui W, The 17th International Symposium of the Hiroshima Cancer Seminar, 2007/11/11, Without Invitation, Hiroshima (Japan)
  128. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach, Sentani K, Oue N, Sakamoto N and Yasui W, The 17th International Symposium of the Hiroshima Cancer Seminar, 2007/11/11, Without Invitation, Hiroshima (Japan)
  129. Reg IV is an independent prognostic indicator of relapse of prostate cancer, Ohara S, Hayashi T, Matsubara A, Usui T, Oue N and Yasui W, The 17th International Symposium of the Hiroshima Cancer Seminar, 2007/11/11, Without Invitation, Hiroshima (Japan)
  130. The effect of activity outside the field of view in estimation of human neuroreceptor binding with PET, Shiraishi T, Shidahara M, Tanimoto K, Ando A, Miyamoto T, Koganezawa R, Fukuda H, Yasui W, Ito K and Watanabe K, 2007 Annual Congress of the European Association of Nuclear Medicine, 2007/11/10, Without Invitation, Copenhagen (Denmark)
  131. Transcriptome dissection of gastric cancer through serial analysis of gene expression to identify novel diagnostic and therapeutic targets, Wataru Yasui, The 14th Seoul International Cancer Symposium, 2007/11, With Invitation, Seoul (Korea)
  132. Microsatellite instability in colorectal cancers among atomic-bomb survivors, Eguchi H, Hamatani K, Taga M, Ito R, Takahashi K, Imai K, Katayama H, Kodama K, Tahara E, Izumi S, Matsumura S, Oue N, Yasui W and Nakachi K, 13th International Congress of Radiation Research, 2007/07/08, Without Invitation, San Francisco, California (USA)
  133. Identification of new serum marker for gastric cancer through SAGE data analysis, Yasui W and Oue N, The 19th Federation of Asia and Oceanian Biochemists and Molecular Biologists (FAOBMB) Conference, 2007/05, With Invitation, Seoul (Korea)
  134. Increased peritoneal metastasis of reg IV-transfected MKN28 gastric carcinoma cells, Kuniyasu H, Kitadai Y, Oue N, Sasahira T, Ohmori H and Yasui W, The 98th Annual Meeting of the American Association for Cancer Research, 2007/04/14, Without Invitation, Los Angeles, California (USA)
  135. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms, Kodama M, Kitadai Y, Tanaka M, Sumida T, Tanaka S, Oue N, Yasui W, Fujii K and Chayama K, The 98th Annual Meeting of the American Association for Cancer Research, 2007/04/14, Without Invitation, Los Angeles, California (USA)
  136. RegIV overexpression inhibits apoptosis, Oue N, Mitani Y, Kamata N and Yasui W, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  137. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer, Hasegawa Y, Matsubara A, Teishima J, Seki M, Mita K, Usui T, Oue N and Yasui W, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  138. Mutations of TP53, KRAS, and EGFR genes in lung cancer from atomic bomb survivors, Taga M, Eguchi H, Hamatani K, Ito R, Katayama H, Kodama K, Tahara E, Matsumura S, Yasui W and Nakachi K, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  139. Microsatellite instability in colorectal cancers among atomic-bomb survivors, Eguchi H, Hamatani K, Taga M, Ito R, Katayama H, Kodama K, Tahara E, Matsumura S, Yasui W and Nakachi K, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  140. Increased peritoneal metastasis of RegIV-transfected MKN28 gastric carcinoma cells, Kuniyasu H, Oue N, Sasahira T, Mitani Y, Ohmori H and Yasui W, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan),
  141. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion, Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W and Kikuchi A, The 16th International Symposium of the Hiroshima Cancer Seminar, 2006/10/22, Without Invitation, Hiroshima (Japan)
  142. Molecular pathology of gastrointestinal carcinoma: Epigenetic alterations and its diagnostic application, Yasui W, The 5th International Group Training Course of "Histopathological Diagnosis of Early Esophagogastric and Colorectal Carcinomas" (Japan International Cooperation Agency; JICA), 2006/09/07, With Invitation, Japan International Cooperation Agency, Hiroshima (Japan)
  143. High expression of h-Prune in gastric cancer with gastric phenbotype: expression of h-prune is associated with poor survival in gastric cance, Oue N, Kikuchi A and Yasui W, The 11th International Congress of Metastasis Research Society jointed with the 15th Annual Meeting of Japanese Association for Metastasis Research, 2006/09/03, Without Invitation, Tokushima (Japan)
  144. Molecular pathogenesis of gastrointestinal neoplasia: Stomach, Yasui W, Aung PP, Nakayama H and Oue N, The XXVI International Congress of the International Academy of Pathology, 2006/09, With Invitation, Montréal (Canada)
  145. Systematic search for novel biomarker of gastric cancer through SAGE data analysis, Wataru Yasui, The 4th International Conference on Gastroenterological Carcinogenesis, 2006/08, With Invitation, Honolulu, Hawaii (USA)
  146. Systematic collection of tissue specimens and molecular pathological analysis of newly diagnosed solid cancers among Atomic-bomb survivors, Wataru Yasui, The Second Nagasaki Symposium of International Consortium for Medical Care of Hibakusha and Radiation Life Science, 2006/07, With Invitation, Nagasaki (Japan)
  147. p53, EGFR and K-ras mutations in lung cancer among atomic bomb survivors, Taga M, Hagiwara N, Mechanic L, Hussain P, Harris CC, Eguchi H, Ito R, Hamatani K, Imai K, Kodama K, Katayama K, Cologne JB, Tahara E, Nakachi K and Yasui W, The workshop on US-Japan cooperative cancer research program, 2006/02, Without Invitation, Washington (USA)
  148. Molecular analysis on colorectal cancer in atomic bomb survivors, Eguchi H, Hamatani K, Taga M, Ito R, Kodama K, Katayama H, Tahara E, Nakachi K, Matsumura S and Yasui W, The workshop on US-Japan cooperative cancer research program, 2006/02, Without Invitation, Washington (USA)
  149. Down-regulation of claudin-18 and its prognostic impact in gastric cancer, Sanada Y, Oue N, Mitani Y, Aung PP, Yoshida K and Yasui W, The 15th International Symposium of The Hiroshima Cancer Seminar, 2005/10/30, Without Invitation, Hiroshima (Japan)
  150. MAGE gene expression is correlated with resistance to taxan in gastric cancer, Oue N, Suzuki T, Yoshida K and Yasui W, The 15th International Symposium of the Hiroshima cancer Seminar, 2005/10/30, Without Invitation, Hiroshima (Japan)
  151. Identification of MIA as a cancer specific gene and prognostic indicator in gastric cancer, Aung PP, Oue N, Mitani Y, Nakayama H and Yasui W, The 6th International Gastric Cancer Congress, 2005/05/04, Without Invitation, Yokohama (Japan)
  152. Aberrant methylation of three genes associated with retinoid signaling pathway in human gastric cancer, Shutoh M, Oue N, Aung PP, Noguchi T, Nakayama H, Kawahara K and Yasui W, The 6th International Gastric Cancer Congress, 2005/05/04, Without Invitation, Yokohama (Japan)
  153. Expression and effect of cadherin 17 on human gastric carcinomas, Ito R, Oue N, Yoshida Y, Nakayama H, Nakachi K and Yasui W, The 6th International Gastric cancer Congress, 2005/05/04, Without Invitation, Yokohama (Japan)
  154. Screening of cancer specific gene and identification of MIA as a cancer specific gene and prognostic indicator in gastric cancer, Aung PP, Oue N, and Yasui W, The 96th Annual Meeting of the American Association for Cancer Research, 2005/04/16, Without Invitation, Anaheim, California (USA)
  155. Identification of novel genes of gastric cancer through serial analysis of gene expression, Wataru Yasui, The 10th US Japan Clinical Trial Summit Meeting: NEW Era of Gastric and Colorectal Cancer Treatment, 2005/02, With Invitation, Maui, Hawaii (USA)
  156. Identification of genes potentially involved in gastric carcinogenesis through serial analysis of gene expression, Aung PP, Oue N, Mitani Y, Nakayama H and Yasui W, The 25th International Congress of the International Academy of Pathology, 2004/10/10, Without Invitation, Brisbane (Australia),
  157. Caveolin-1 is specifically expressed in human gastric cancer, Ito R, Oue N, Yoshida K, Nakachi K and Yasui W, The 3rd International Conference on Gastroenterological Carcinogenesis, 2004/08/19, Without Invitation, Sapporo (Japan)
  158. Search for novel genes of gastric cancer through serial analysis of gene expression, Aung PP, Oue N, Mitani Y, Nakayama H and Yasui W, The 3rd International Conference on Gastroenterological Carcinogenesis, 2004/08/19, Without Invitation, Sapporo (Japan)
  159. Identification of genes involved in invasion and metastasis of gastric cancer by serial analysis of gene expression, Yasui W, Oue N, Mitani Y, Hamai Y, Ito R and Nakayama H, The 3rd International Conference on Gastroenterological Carcinogenesis, 2004/08, With Invitation, Sapporo (Japan)
  160. Expression of cadherin-17 is associated with advanced stage of gastric carcinoma, Ito R, Oue N, Motoshita J, Nakayama H, Kuraoka K, Yoshida K and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  161. A single nucleotide polymorphism in the MMP-9 promoter is correlated with tumor progression and malignant phenotype of gastric cancer, Matsumura S, Oue N, Hamai Y, Kitadai Y, Chayama K, Yoshida K, Imai K, Nakachi K and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  162. DNA hyper methylation and histone hypoacetylation of the HLTF gene is associated with reduced expression in gastric carcinoma, Hamai Y, Oue N, Mitani Y, Ito R, Matsusaki K, Yoshida K, Toge T and Yasui W, The 95th Annual Meeting of the American Association for cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  163. Histone hypoacetylation and reduced expression of p21waf1 in gastric carcinoma, Mitani Y, Oue N, Nakayama H, Sugiyama M, Ishikawa T and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  164. Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis using serial analysis of gene expression, Oue N, Hamai Y, Mitani Y, Matsumura S, Aung PP, Kuraoka K, Yoshida K, Nakayama H and Yasui W, The 95th Annual Meeting of the American Association for Cancer Research, 2004/03/27, Without Invitation, Orlando, Florida (USA)
  165. Molecular pathology of gastric cancer and its diagnostic application, Wataru Yasui, Fifth People Hospital affiliated to Fudan University, 2003/11, With Invitation, Shanghai (China)
  166. Search for novel markers of gastric cancer through global analysis of gene expression profiles and its clinical implication, Wataru Yasui, "Research Institute of Surgery, Third Military Medical University", 2003/11, With Invitation, Chongqing (China)
  167. Search for new biomarkers of gastric cancer through serial analysis of gene expression, Wataru Yasui, The 13th International Symposium of the Hiroshima Cancer Seminar, 2003/10, With Invitation, Hiroshima (Japan)
  168. Expression of Cbl and its correlation with EGFR expression in gastric carcinomas, Ito R, Oue N, Kuraoka K, Yoshida K, Nakayama H and Yasui W, The 94th Annual Meeting of the American Association for Cancer Research, 2003/07/11, Without Invitation, Washington, D.C. (USA)
  169. Helicobacter pylori infection enhances gene expression related to angiogenesis and invasion by human gastric carcinoma cells, Kitadai Y, Sasaki a, Tanaka S, Oue N, Yasui W and Chayama K, The 94th Annual Meeting of the American Association for cancer Research, 2003/07/11, Without Invitation, Washington, D.C. (USA)
  170. Expression of RhoC is associated with metastasis of gastric carcinomas, Kondo T, Sentani K, Oue N, Matsumura S, Ito R, Nakayama H and Yasui W, The 12th International Symposium of the Hiroshima Cancer Seminar, 2002/11/10, Without Invitation, Hiroshima (Japan)
  171. Expression of PRL-3, a metastasis related phosphatase gene, in human gastric carcinomas, Yokozaki H, Oue N, Maskad UA, Kato H Matsumoto N, Semba S and Yasui W, The 12th international Symposium of the Hiroshima Cancer Seminar, 2002/11/10, Without Invitation, Hiroshima (Japan)
  172. Altered histone acetylation and gene expression in gastrointestinal cancer, Wataru Yasui, "RERF (Radiation Effects Research Foundation) Lecture, Special lecture", 2002/09, With Invitation, Hiroshima (Japan)
  173. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa, Kitadai Y, Amioka T, Tanaka S, Akagi M, Yasui W and Chayama K, The 93rd Annual Meeting of the American Association for Cancer Research, 2002/04/06, Without Invitation, San Francisco, California (USA)
  174. Altered histone acetylation and gene expression in human cancers, Wataru Yasui, "NCI Special Meeting ""Epigenetic Mechanisms in Human Disease""", 2002/03, With Invitation, Bethesda, Maryland (USA)
  175. Molecular mechanism of gastrointestinal carcinogenesis and its application to Molecular diagnosis, Wataru Yasui, The 5th International Conference of the Asian Clinical Oncology Society, 2001/04, With Invitation, Taipei (Chinese Taipei)
  176. Interleukin-15 expression is associated with malignant potential in colon cancer cells, Kuniyasu H, Oue N, Fujimoto J, Yokozaki H and Yasui W, The 92nd Annual Meeting of The American Association for Cancer Research, 2001/03/24, Without Invitation, New Orleans, Louisiana (USA)
  177. CpG island methylation of hMLH1, p16, E-cadherin and MGMT and the expression of DNA methyltransferase and demethylase in gastric carcinomas, Oue N, Kuniyasu H, Yokozaki H, Fujimoto J, Kuraoka K and Yasui W, The Fifth Joint Conference of the American association for Cancer Research and the Japanese Cancer Association, 2001/02/12, Without Invitation, Maui, Hawaii (USA)
  178. Practical molecular-pathological diagnosis of gastrointestinal tumors, Wataru Yasui, The 7th International Symposium of the Aichi Cancer Center, 2001/01, With Invitation, Nagoya (Japan)
  179. Molecular-pathological diagnosis system using routine histopathology specimens, Wataru Yasui, The 10th International Symposium of the Hiroshima Cancer Seminar, 2000/10, With Invitation, Hiroshima (Japan)
  180. Molecular diagnosis of gastrointestinal tumors, Yokozaki H and Yasui W, The 22nd International Congress of the International Academy of Pathology, 2000/10, With Invitation, Nagoya (Japan)
  181. Molecular-pathological apects of stomach carcinogenesis and its application to molecular diagnosis, Wataru Yasui, The 22nd International Congress of the International Academy of Pathology, 2000/10, With Invitation, Nagoya (Japan)
  182. Growth inhibition by retinoic acid and its molecular mechanism in oral carcinoma cells, Wataru Yasui, The 4th International Conference of the Asian Clinical Oncology Society, 1999/08, With Invitation
  183. Molecular mechanism of gastric carcinogenesis and molecular diagnosis, The 3rd International Gastric Cancer Congress, 1999/04, With Invitation
  184. Recent advances in molecular mechanisms of human stomach carcinogenesis, Wataru Yasui, The Second International Conference on Gastroenterological Carcinogenesis, 1999/03, With Invitation
  185. Gastric Carcinoma - State of the Art -: Genetic and epigenetic alterations in multistep carcinogenesis of the stomach, Wataru Yasui, The Centennial Anniversary Meeting of the Japanese Society of Gastroenterology", 1998/10, With Invitation
  186. Genetic and epigenetic alterations in gastric cancer. Application to molecular diagnosis, Wataru Yasui, The 17th International Cancer Congress, 1998/08, With Invitation
  187. Future directions: Molecular diagnosis of gastric cancer - Malignant potential -, Wataru Yasui, The 11th International Symposium of the Foundation for Promotion of Cancer Research ''Basic and Clinical Research in Gastric Cancer', 1998/04, With Invitation
  188. Can we regard intestinal metaplasia as a premalignant condition?: From genetic basis, Wataru Yasui, The 11th International Symposium of the Foundation for Promotion of Cancer Research ''Basic and Clinical Research in Gastric Cancer', 1998/04, With Invitation
  189. Molecular diagnosis of early gastric cancer, Wataru Yasui, The 8th Annual Meeting of the Korea University Cancer Research Instititue, 1997/11, With Invitation
  190. Practical molecular diagnosis on gastrointestinal biopsies, Wataru Yasui, The First International Conference on Gastroenterological Carcinogenesis, 1996/10, With Invitation
  191. Molecular biology of stomach cancer and its application to molecular diagnosis, Wataru Yasui, "Special lecture at the Institute of Pathology, University of Erlangen-Nurnberg", 1995/03, With Invitation
  192. Molecular basis of stomach carcinogenesis, Wataru Yasui, WHO-CC 10th International Seminar and Workshop and 5th General Meeting, 1993/09, With Invitation
  193. Gene alterations in intestinal metaplasia and gastric cancer, Wataru Yasui, International Symposium on Helicobacter pylori and its disease, 1993/09, With Invitation
  194. p53 gene abnormalities in human gastric carcinoma, Wataru Yasui, The Second Joint Meeting of American association for Cancer Research and Japanese Cancer Association, 1992/02, With Invitation

Awards

  1. 2013年, Distinguished Professor, Hiroshima University
  2. 2009年11月25日, Hiroshima University President Award, Hiroshima University, Identification of new diagnostic and therapeutic targets of gastric cancer through SAGE data analysis
  3. 2008年05月, Japan Pathology Award, Japanese Society of Pathology, Transcriptome dissection of gastric cancer - Discovery of seeds from tissue sample and its application to diagnosis and treatment -
  4. 2008年02月, Research Grant Award of Prince Takamatsu Cancer Research Fund, Prince Takamatsu Cancer Research Fund, Search for novel diagnostic and therapeutic targets of GI cancer by SAGE and CAST methods
  5. 1997年11月, Japan Pathology Research Award, Japanese Society of Pathology, Molecular pathological diagnosis on biopsy and surgical specimens of gastrointestinal tract

Patented

  1. Patent, JP5055543, 2012/08/10
  2. Patent, JP5467256, 2014/02/07

Social Activities

History as Committee Members

  1. Associate Member, 2017/10/02, 2023/09/30, Science Council of Japan
  2. Associate member, 2006/08/20, 2008/09/30, Science Council of Japan
  3. Vice-chairman, 2016/05, 2020/05, Japanese Society of Pathology
  4. Director, 2014/01, 2019/12, Japanese Cancer Association
  5. Japanese Gastric Cancer Association, Auditor, 2018/03, Japanese Gastric Cancer Association
  6. Director, 2004, 2021/03, International Society of Gastroenterological Carcinogenesis
  7. Council member, 2016, 2021/03, International Gastric Cancer Association
  8. Councilor, 1998, 2021/03, Japanese Society for Metastasis Research
  9. Executive Director, 2000/06, Hiroshima Cancer Seminar Foundation
  10. Hiroshima Prefecture Medical Council committee member, 2014/08, 2018/03, Hiroshima Prefecture
  11. Hiroshima Prefecture Cancer Control Committee member, 2015/11, Hiroshima Prefecture
  12. Director, 2014/04/01, NPO Promotion of Pathology for Cancer Patient Care
  13. Director, 2012/04/02, 2021/03/31, NPO Integrated Telemedicine Support Organization
  14. NHK Chugoku Broadcast Program Council Committee Chairman, 2015/05, 2019/04, NHK Hiroshima Broadcasting Station
  15. President, The 89th Annual Meeting of the Japanese Gastric Cancer Association, 2017/03, 2017/03, Japanese Gastric Cancer Association
  16. President, The 103rd Annual Meeting of the Japanese Society of Pathology, 2014/04/26, 2014/04/28, Japanese Society of Pathology
  17. President, The 26th Annual Meeting of the Japanese Association for Metastasis Research, 2011/07, 2012/07, Japanese Association for Metastasis Research
  18. President, The 30th Annual Meeting of the Japan Society for Molecular Tumor Marker Research, 2010/09, 2010/09, Japan Society for Molecular Tumor Marker Research
  19. President, The 20th Annual Meeting of the Japanese Society of Gastroenterological Carcinogenesis, 2009/11/26, 2009/11/27, Japanese Society of Gastroenterological Carcinogenesis
  20. President, The First Conference of the Japanese Society of Pathology, 2004/07, 2004/07, Japanese Society of Pathology
  21. President, The 23rd Annual Meeting of the Japanese Research Society of Molecular Pathology, 2004/07, 2004/08, Japanese Research Society of Molecular Pathology

Organizing Academic Conferences, etc.

  1. The 125th Meeting of the Japanese Society of Pathology Chugoku-Shikoku Branch, Organizer, 2018/02, 2018/02
  2. The 10th Kure International Medical Forum, Advisory Board Member, 2017/07, 2017/07
  3. 12th International Gastric Cancer Congress, International Academic Committee member, 2017/04, 2017/04
  4. 89th Annual Meeting of the Japanese Gastric Cancer Association, Congress President, 2017/03, 2017/03
  5. GAP-related Meeting between Hiroshima University and the University of Texas MD Anderson Cancer Center, Organizing Committee Member, 2016/07, 2016/07
  6. 11th International Gastric Cancer Congress, International Scientific Committee member, 2015/06, 2015/06
  7. The 34th Sapporo International Cancer Symposium, Program Committee Member, 2015/06, 2015/06
  8. The 103rd Annual Meeting of the Japanese Society of Pathology, President, 2014/04, 2014/04
  9. The 4th JCA-AACR Special Joint Conference, Organizer, 2013/12, 2013/12
  10. The 21st Annual Meeting of the Japanese Society for Metastasis Research, President, 2012/07, 2012/07
  11. The 19th Open Seminar of the Japanese Cancer Association, 2012/06, 2012/06
  12. 8th International Symposium on Minimal Residual Cancer, Organizing Committee member, 2011/09, 2011/09
  13. The 12th Pathology Summer School for Undergraduates, 2011/08
  14. The 3rd CREST-SBM International Conference “Mathematical Methods in Cancer Cell Biology”, Organizing Committee member, 2011/06, 2011/06
  15. 9th International Gastric Cancer Congress, International Scientific Committee member, 2011/04, 2011/04
  16. The 30th Annual Meeting of the Japanese Society for Molecular Tumor Marker Research, President, 2010/09, 2010/09
  17. The 19th International Symposium of Hiroshima Cancer Seminar, 2009/11, 2009/11
  18. The 20th Annual Meeting of the Japanese Society of Gastroenterological Carcinogenesis, President, 2009/11, 2009/11
  19. 8th International Gastric Cancer Congress, International Scientific Committee member, 2009/06, 2009/06
  20. 36th Congress of the International Society for Oncodevelopmental Biology and Medicine, Organizing Committee member, 2008/10, 2008/10
  21. The 95th Slide Seminar and Scientific Meeting of the Japanese Society of Pathology -Chugoku-Shikoku Branch, 2008/02, 2008/02
  22. The 6th Technical Seminar of the Japanese Society of Pathology, 2006/11
  23. The 1st Conference of the Japanese Society of Pathology , Chairman, 2004/07, 2004/07
  24. The 23rd Annual Meeting of the Research Society of Molecular Pathology , President, 2004/07
  25. The 58 Annual Meeting of the Japanese Cancer Association, 1999/09
  26. The 87th Annual Meeting of the Japanese Society of Pathology, 1998/04
  27. The first International Congress of the International Society of Gastroenterological Carcinogenesis, 1996/10
  28. The 8th Internartional Congress of the International Society of Differentiation , 1994/10

History as Peer Reviews of Academic Papers

  1. 2019, Pathobiology, Editorial Board
  2. 2019, Cancer Science, Associate Editor
  3. 2019, Pathology International, Editorial Board
  4. 2019, Gastric Cancer, Editor
  5. 2019, Japanese Journal of Clinical Oncology, Associate Editor
  6. 2019, International Journal of Clinical Oncology, Editorial Board
  7. 2019, Gastric Cancer Perspective, Editor
  8. 2018, Pathobiology, Editor Far East
  9. 2018, cancer Science, Associate Editor
  10. 2018, Gastric Cancer, Editor
  11. 2018, Japanese Journal of Clinical Oncology, Associate Editor
  12. 2018, International Journal of Clinical Oncology, Editorial Board
  13. 2018, Oncology, Editorial Board
  14. 2018, Pathology International, Editorial Board
  15. 2018, Gastric Cancer Perspective, Editor
  16. 2017, Pathobiology, Editor Far East
  17. 2017, Cancer Science, Associate Editor
  18. 2017, Pathology International, Editorial Board
  19. 2017, Oncology, Editorial Board
  20. 2017, Japanese Journal of Clinical Oncology, Associate Editor
  21. 2017, Gastric Cancer, Editor
  22. 2017, Gastric Cancer Perspective, Editor
  23. 2017, International Journal of Clinical Oncology, Editorial Board
  24. 2016, Pathobiology, Editor-Far East
  25. 2016, Gastric Cancer, Editor
  26. 2016, Cancer Science, Associate Editor
  27. 2016, Pathology International, Editorial Board
  28. 2016, Oncology, Editorial Board
  29. 2016, Japanese Journal of Clinical Oncology, Associate Editor
  30. 2016, Gastric Cancer Perspective, Editor
  31. 2016, International Journal of Clinical Oncology, Editorial Board
  32. 2015, Pathobiology, Editor-Far East
  33. 2015, Cancer Science, Associate Editor
  34. 2015, Gastric Cancer, Editor
  35. 2015, Japanese Journal of Clinical Oncology, Associate Editor
  36. 2015, Oncology, Editorial Board
  37. 2015, Pathology International, Editorial Board
  38. 2015, Gastric Cancer Perspective, Editor
  39. 2014, Pathology and Clinical Medicine, Editor
  40. 2014, Gastric Cancer Perspective, Editor